Trial Outcomes & Findings for Epidemiology Study of Malaria Transmission Intensity in Sub-Saharan Africa (NCT NCT02251704)

Last Updated: 2025-07-24

Results Overview

The number of participants was summarized by the WHO age group (0.5-1 year \[Y\] and 2-9Y) and by center number/ country \[Burkina Faso (BF), Senegal (SN), Tanzania (TZ), Kenya (KE), Ghana (GH), Malawi (MA)\]/ city. Unexposed (UNEXP) sites are the ones in which the RTS,S vaccine was not planned to be implemented during the course of the study however, vaccinated participants could still have been randomly selected in this population if vaccination happened in an exposed (EXP) site, due to cross-site migration. The infection was identified using a blood smear slide and determined using microscopy.

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

54115 participants

Primary outcome timeframe

At Day 1 (survey completion visit)

Results posted on

2025-07-24

Participant Flow

Participants were enrolled from Health and Demographic Surveillance System (HDSS) (or equivalent system) catchment areas at the sites participating in the EPI-MAL-002 (NCT02374450) and EPI-MAL-003 (NCT03855995) studies of the candidate malaria vaccine RTS,S/AS01E in sub-Saharan Africa.

Out of 54115 participants enrolled, 54100 participants were included in the Total Effective Cohort and started the study.

Participant milestones

Participant milestones
Measure	Survey 1 Group Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 1.	Survey 2 Group Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 2.	Survey 3 Group Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 3.	Survey 4 Group Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 4.	Survey 5 Group Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 5.	Survey 6 Group Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 6.	Survey 7 Group Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 7.	Survey 8 Group Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 8.	Survey 9 Group Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 9.	Survey 10 Group Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 10.
Overall Study STARTED	4214	4204	2400	3003	5417	5991	7246	7220	7203	7202
Overall Study COMPLETED	4214	4204	2400	3003	5417	5991	7246	7220	7203	7202
Overall Study NOT COMPLETED	0	0	0	0	0	0	0	0	0	0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

The Age Continuous analysis is presented separately for each of the 10-survey year.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure	Survey 1 Group n=4214 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 1.	Survey 2 Group n=4204 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 2.	Survey 3 Group n=2400 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 3.	Survey 4 Group n=3003 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 4.	Survey 5 Group n=5417 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 5.	Survey 6 Group n=5991 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 6.	Survey 7 Group n=7246 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 7.	Survey 8 Group n=7220 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 8.	Survey 9 Group n=7203 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 9.	Survey 10 Group n=7202 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 10.	Total n=54100 Participants Total of all reporting groups
Age, Continuous Year 1	4.0 Years STANDARD_DEVIATION 2.8 • n=4214 Participants • The Age Continuous analysis is presented separately for each of the 10-survey year.	—	—	—	—	—	—	—	—	—	4.0 Years STANDARD_DEVIATION 2.8 • n=4214 Participants • The Age Continuous analysis is presented separately for each of the 10-survey year.
Age, Continuous Year 2	—	4.0 Years STANDARD_DEVIATION 2.7 • n=4204 Participants • The Age Continuous analysis is presented separately for each of the 10-survey year.	—	—	—	—	—	—	—	—	4.0 Years STANDARD_DEVIATION 2.7 • n=4204 Participants • The Age Continuous analysis is presented separately for each of the 10-survey year.
Age, Continuous Year 3	—	—	4.0 Years STANDARD_DEVIATION 2.8 • n=2400 Participants • The Age Continuous analysis is presented separately for each of the 10-survey year.	—	—	—	—	—	—	—	4.0 Years STANDARD_DEVIATION 2.8 • n=2400 Participants • The Age Continuous analysis is presented separately for each of the 10-survey year.
Age, Continuous Year 4	—	—	—	4.0 Years STANDARD_DEVIATION 2.8 • n=3003 Participants • The Age Continuous analysis is presented separately for each of the 10-survey year.	—	—	—	—	—	—	4.0 Years STANDARD_DEVIATION 2.8 • n=3003 Participants • The Age Continuous analysis is presented separately for each of the 10-survey year.
Age, Continuous Year 5	—	—	—	—	4.1 Years STANDARD_DEVIATION 2.7 • n=5417 Participants • The Age Continuous analysis is presented separately for each of the 10-survey year.	—	—	—	—	—	4.1 Years STANDARD_DEVIATION 2.7 • n=5417 Participants • The Age Continuous analysis is presented separately for each of the 10-survey year.
Age, Continuous Year 6	—	—	—	—	—	4.0 Years STANDARD_DEVIATION 2.7 • n=5991 Participants • The Age Continuous analysis is presented separately for each of the 10-survey year.	—	—	—	—	4.0 Years STANDARD_DEVIATION 2.7 • n=5991 Participants • The Age Continuous analysis is presented separately for each of the 10-survey year.
Age, Continuous Year 7	—	—	—	—	—	—	4.1 Years STANDARD_DEVIATION 2.7 • n=7246 Participants • The Age Continuous analysis is presented separately for each of the 10-survey year.	—	—	—	4.1 Years STANDARD_DEVIATION 2.7 • n=7246 Participants • The Age Continuous analysis is presented separately for each of the 10-survey year.
Age, Continuous Year 8	—	—	—	—	—	—	—	4.0 Years STANDARD_DEVIATION 2.7 • n=7220 Participants • The Age Continuous analysis is presented separately for each of the 10-survey year.	—	—	4.0 Years STANDARD_DEVIATION 2.7 • n=7220 Participants • The Age Continuous analysis is presented separately for each of the 10-survey year.
Age, Continuous Year 9	—	—	—	—	—	—	—	—	4.0 Years STANDARD_DEVIATION 2.7 • n=7203 Participants • The Age Continuous analysis is presented separately for each of the 10-survey year.	—	4.0 Years STANDARD_DEVIATION 2.7 • n=7203 Participants • The Age Continuous analysis is presented separately for each of the 10-survey year.
Age, Continuous Year 10	—	—	—	—	—	—	—	—	—	4.0 Years STANDARD_DEVIATION 2.7 • n=7202 Participants • The Age Continuous analysis is presented separately for each of the 10-survey year.	4.0 Years STANDARD_DEVIATION 2.7 • n=7202 Participants • The Age Continuous analysis is presented separately for each of the 10-survey year.
Sex: Female, Male Female	2053 Participants n=4214 Participants	2090 Participants n=4204 Participants	1191 Participants n=2400 Participants	1448 Participants n=3003 Participants	2642 Participants n=5417 Participants	2963 Participants n=5991 Participants	3626 Participants n=7246 Participants	3660 Participants n=7220 Participants	3505 Participants n=7203 Participants	3593 Participants n=7202 Participants	26771 Participants n=54100 Participants
Sex: Female, Male Male	2161 Participants n=4214 Participants	2114 Participants n=4204 Participants	1209 Participants n=2400 Participants	1555 Participants n=3003 Participants	2775 Participants n=5417 Participants	3028 Participants n=5991 Participants	3620 Participants n=7246 Participants	3560 Participants n=7220 Participants	3698 Participants n=7203 Participants	3609 Participants n=7202 Participants	27329 Participants n=54100 Participants
Race and Ethnicity Not Collected	—	—	—	—	—	—	—	—	—	—	0 Participants Race and Ethnicity were not collected from any participant.

PRIMARY outcome

Timeframe: At Day 1 (survey completion visit)

Population: The analysis was performed on the According To Protocol (ATP) Cohort which included all participants who met the eligibility criteria, adhered to the procedures defined in the protocol, had no elimination criteria during the study, had at least one laboratory result from a blood sample available and with usable data for the specified analysis at the specified time point. Here, 'number analyzed' = participants with available data for each specified row.

Outcome measures

Outcome measures
Measure	Survey 1 Group n=424 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 1.	Survey 2 Group n=425 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 2.	Survey 3 Group n=420 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 3.	Survey 4 Group n=430 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 4.	Survey 5 Group n=431 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 5.	Survey 6 Group n=430 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 6.	Survey 7 Group n=442 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 7.	Survey 8 Group n=427 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 8.	Survey 9 Group n=427 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 9.	Survey 10 Group n=427 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 10.
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 0.5-1Y, 207082_KE_Kombewa	32 Participants	47 Participants	47 Participants	46 Participants	44 Participants	47 Participants	27 Participants	26 Participants	27 Participants	17 Participants
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 0.5-1Y, 207083_GH_Kintampo	33 Participants	36 Participants	—	—	—	—	—	—	—	—
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 0.5-1Y, 207084_SN_Keur Soce	0 Participants	1 Participants	—	—	—	—	—	—	—	—
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 0 .5-1Y, 228607_GH_Navrongo_EXP	—	—	—	7 Participants	7 Participants	7 Participants	3 Participants	4 Participants	8 Participants	4 Participants
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 0.5-1Y, 228607_GH_Navrongo_UNEXP	—	—	—	—	—	9 Participants	9 Participants	5 Participants	7 Participants	4 Participants
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 2-9Y, 228607_GH_Navrongo_UNEXP	—	—	—	—	—	97 Participants	86 Participants	70 Participants	82 Participants	91 Participants
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 0 .5-1Y, 233150_MA_Chikwawa	—	—	—	—	7 Participants	0 Participants	12 Participants	2 Participants	1 Participants	3 Participants
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 0 .5-1Y, 233149_MA_Monkey Bay	—	—	—	—	11 Participants	1 Participants	6 Participants	6 Participants	5 Participants	8 Participants
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 2-9Y, 233149_MA_Monkey Bay	—	—	—	—	52 Participants	34 Participants	28 Participants	32 Participants	39 Participants	40 Participants
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 0 .5-1Y, 207083_GH_Kintampo_EXP	—	—	41 Participants	42 Participants	22 Participants	20 Participants	14 Participants	10 Participants	6 Participants	3 Participants
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 0.5-1Y, 207083_GH_Kintampo_UNEXP	—	—	—	—	—	29 Participants	22 Participants	15 Participants	17 Participants	8 Participants
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 0 .5-1Y, 233149_MA_Mangochi	—	—	—	—	16 Participants	7 Participants	9 Participants	15 Participants	4 Participants	3 Participants
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 0 .5-1Y, 233150_MA_St Monfort	—	—	—	—	3 Participants	—	9 Participants	1 Participants	0 Participants	2 Participants
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 2-9Y, 233150_MA_Chikwawa	—	—	—	—	62 Participants	—	85 Participants	30 Participants	16 Participants	22 Participants
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 0 .5-1Y, 235578_KE_Bondo	—	—	—	—	28 Participants	32 Participants	29 Participants	15 Participants	19 Participants	13 Participants
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 0 .5-1Y, 235578_KE_Gem	—	—	—	—	31 Participants	20 Participants	13 Participants	20 Participants	20 Participants	13 Participants
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 0.5-1Y, 235579_KE_Nyando	—	—	—	—	—	32 Participants	18 Participants	15 Participants	15 Participants	13 Participants
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 2-9Y, 207078_BF_Nouna	305 Participants	340 Participants	270 Participants	211 Participants	—	—	—	—	—	—
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 2-9Y, 207079_BF_Sapone	253 Participants	262 Participants	172 Participants	173 Participants	—	—	—	—	—	—
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 2-9Y, 207080_SN_Niakhar	7 Participants	3 Participants	—	—	—	—	—	—	—	—
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 2-9Y, 207081_TZ_Korogwe	57 Participants	16 Participants	—	—	—	—	—	—	—	—
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 2-9Y, 207082_KE_Kombewa	164 Participants	142 Participants	166 Participants	165 Participants	143 Participants	138 Participants	107 Participants	97 Participants	97 Participants	101 Participants
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 2-9Y, 207083_GH_Kintampo	181 Participants	176 Participants	—	—	—	—	—	—	—	—
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 2-9Y, 233150_MA_St Monfort	—	—	—	—	35 Participants	—	44 Participants	13 Participants	2 Participants	2 Participants
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 2-9Y, 235578_KE_Bondo	—	—	—	—	130 Participants	147 Participants	110 Participants	112 Participants	86 Participants	73 Participants
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 2-9Y, 235578_KE_Gem	—	—	—	—	115 Participants	111 Participants	102 Participants	86 Participants	90 Participants	75 Participants
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 2-9Y, 235579_KE_Nyando	—	—	—	—	—	121 Participants	89 Participants	59 Participants	79 Participants	76 Participants
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 2-9Y, 207083_GH_Kintampo_EXP	—	—	184 Participants	144 Participants	131 Participants	99 Participants	89 Participants	64 Participants	57 Participants	49 Participants
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 2-9Y, 207083_GH_Kintampo_UNEXP	—	—	—	—	—	126 Participants	111 Participants	84 Participants	74 Participants	59 Participants
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 2-9Y, 207084_SN_Keur Soce	3 Participants	5 Participants	—	—	—	—	—	—	—	—
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 2-9Y, 228607_GH_Navrongo_EXP	—	—	—	93 Participants	103 Participants	90 Participants	74 Participants	65 Participants	66 Participants	70 Participants
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 2-9Y, 233149_MA_Mangochi	—	—	—	—	82 Participants	79 Participants	42 Participants	63 Participants	39 Participants	61 Participants
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 0.5-1Y, 207078_BF_Nouna	98 Participants	148 Participants	82 Participants	46 Participants	—	—	—	—	—	—
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 0.5-1Y, 207079_BF_Sapone	46 Participants	54 Participants	22 Participants	31 Participants	—	—	—	—	—	—
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 0.5-1Y, 207080_SN_Niakhar	2 Participants	0 Participants	—	—	—	—	—	—	—	—
Number of Participants Infected With Plasmodium Falciparum (P. Falciparum) by World Health Organisation (WHO) Age Group 0.5-1Y, 207081_TZ_Korogwe	6 Participants	2 Participants	—	—	—	—	—	—	—	—

PRIMARY outcome

Timeframe: At Day 1 (survey completion visit)

Population: The analysis was performed on the ATP Cohort which included all participants who met the eligibility criteria, adhered to the procedures defined in the protocol, had no elimination criteria during the study, had at least one laboratory result from a blood sample available and with usable data for the specified analysis at the specified time point. Here, 'number analyzed' = participants with available data for each specified row.

The number of participants was summarized by the JTEG age group (0.5-4Y and 5-9Y) by center number/ country \[BF, SN, TZ, KE, GH, MA\]/ city. UNEXP sites are the ones in which the RTS,S vaccine was not planned to be implemented during the course of the study however, vaccinated participants could still have been randomly selected in this population if vaccination happened in an EXP site, due to cross-site migration. The infection was identified using a blood smear slide and determined using microscopy.

Outcome measures

Outcome measures
Measure	Survey 1 Group n=404 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 1.	Survey 2 Group n=401 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 2.	Survey 3 Group n=401 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 3.	Survey 4 Group n=403 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 4.	Survey 5 Group n=405 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 5.	Survey 6 Group n=402 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 6.	Survey 7 Group n=415 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 7.	Survey 8 Group n=412 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 8.	Survey 9 Group n=403 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 9.	Survey 10 Group n=408 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 10.
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 0.5-4Y, 207078_BF_Nouna	249 Participants	321 Participants	198 Participants	135 Participants	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 0.5-4Y, 207079_BF_Sapone	162 Participants	182 Participants	75 Participants	94 Participants	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 0.5-4Y, 207082_KE_Kombewa	100 Participants	108 Participants	119 Participants	132 Participants	109 Participants	111 Participants	76 Participants	68 Participants	64 Participants	51 Participants
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 0.5-4Y, 207083_GH_Kintampo	99 Participants	109 Participants	—	—	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 0.5-4Y, 207083_GH_Kintampo_UNEXP	—	—	—	—	0 Participants	81 Participants	66 Participants	58 Participants	42 Participants	33 Participants
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 0 .5-4Y, 233150_MA_Chikwawa	—	—	—	—	33 Participants	0 Participants	43 Participants	10 Participants	7 Participants	12 Participants
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 0 .5-4Y, 233150_MA_St Monfort	—	—	—	—	17 Participants	—	27 Participants	5 Participants	0 Participants	2 Participants
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 0 .5-4Y, 235578_KE_Bondo	—	—	—	—	94 Participants	99 Participants	74 Participants	63 Participants	55 Participants	44 Participants
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 0 .5-4Y, 235578_KE_Gem	—	—	—	—	80 Participants	64 Participants	48 Participants	55 Participants	48 Participants	43 Participants
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 0.5-4Y, 235579_KE_Nyando	—	—	—	—	0 Participants	83 Participants	48 Participants	41 Participants	43 Participants	39 Participants
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 5-9Y, 207081_TZ_Korogwe	34 Participants	12 Participants	—	—	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 5-9Y, 207083_GH_Kintampo_EXP	—	—	108 Participants	83 Participants	73 Participants	66 Participants	58 Participants	49 Participants	39 Participants	29 Participants
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 5-9Y, 228607_GH_Navrongo_UNEXP	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	80 Participants	67 Participants	48 Participants	61 Participants	59 Participants
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 5-9Y, 233149_MA_Mangochi	—	—	—	—	47 Participants	47 Participants	24 Participants	44 Participants	51 Participants	36 Participants
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 5-9Y, 233149_MA_Monkey Bay	—	—	—	—	36 Participants	27 Participants	16 Participants	23 Participants	51 Participants	26 Participants
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 5-9Y, 233150_MA_Chikwawa	—	—	—	—	36 Participants	0 Participants	54 Participants	22 Participants	10 Participants	13 Participants
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 5-9Y, 233150_MA_St Monfort	—	—	—	—	21 Participants	0 Participants	26 Participants	9 Participants	10 Participants	2 Participants
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 5-9Y, 235579_KE_Nyando	—	—	—	—	—	70 Participants	59 Participants	33 Participants	51 Participants	50 Participants
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 5-9Y, 235578_KE_Bondo	—	—	—	—	64 Participants	80 Participants	65 Participants	64 Participants	50 Participants	42 Participants
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 5-9Y, 235578_KE_Gem	—	—	—	—	66 Participants	67 Participants	67 Participants	51 Participants	62 Participants	45 Participants
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 0.5-4Y, 207080_SN_Niakhar	6 Participants	1 Participants	—	—	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 0.5-4Y, 207081_TZ_Korogwe	29 Participants	6 Participants	—	—	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 0 .5-4Y, 207083_GH_Kintampo_EXP	—	—	117 Participants	103 Participants	40 Participants	53 Participants	45 Participants	25 Participants	24 Participants	23 Participants
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 0.5-4Y, 207084_SN_Keur Soce	2 Participants	4 Participants	—	—	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 0 .5-4Y, 228607_GH_Navrongo_EXP	—	—	—	31 Participants	40 Participants	32 Participants	19 Participants	14 Participants	25 Participants	22 Participants
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 0.5-4Y, 228607_GH_Navrongo_UNEXP	—	—	—	—	—	26 Participants	28 Participants	27 Participants	28 Participants	36 Participants
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 0 .5-4Y, 233149_MA_Mangochi	—	—	—	—	51 Participants	39 Participants	27 Participants	34 Participants	24 Participants	28 Participants
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 0 .5-4Y, 233149_MA_Monkey Bay	—	—	—	—	27 Participants	8 Participants	18 Participants	15 Participants	19 Participants	22 Participants
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 5-9Y, 207078_BF_Nouna	154 Participants	167 Participants	154 Participants	122 Participants	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 5-9Y, 207079_BF_Sapone	137 Participants	134 Participants	119 Participants	110 Participants	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 5-9Y, 207080_SN_Niakhar	3 Participants	2 Participants	—	—	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 5-9Y, 207082_KE_Kombewa	96 Participants	81 Participants	94 Participants	79 Participants	78 Participants	74 Participants	58 Participants	55 Participants	60 Participants	67 Participants
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 5-9Y, 207083_GH_Kintampo	115 Participants	103 Participants	—	—	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 5-9Y, 207083_GH_Kintampo_UNEXP	—	—	—	—	—	74 Participants	67 Participants	41 Participants	49 Participants	34 Participants
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 5-9Y, 207084_SN_Keur Soce	1 Participants	2 Participants	—	—	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Joint Technical Expert Group (JTEG) Age Group 5-9Y, 228607_GH_Navrongo_EXP	—	—	—	69 Participants	70 Participants	65 Participants	58 Participants	55 Participants	49 Participants	52 Participants

PRIMARY outcome

Timeframe: At Day 1 (survey completion visit)

The number of participants using malaria control interventions was summarized by: participants sleeping under a mosquito net the night before their visit, participants who have a new bednet (less than 1 year), participants who have a impregnated bednet (dipped in liquid to repel mosquitos after purchase), participants who have a pierced/torn bednet, participants with bednets classified by hole size (defined as holes big enough to let one finger go through) and number of holes (less than \[\<\] 5 holes, more or equal \[\>=\] to 5 holes, not applicable \[NA\] which is a participant who did not sleep under a bed net, missing confirmed \[MC\] which is a participant who slept under a mosquito net but who didn't answer to the question on holes).

Outcome measures

Outcome measures
Measure	Survey 1 Group n=4208 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 1.	Survey 2 Group n=4199 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 2.	Survey 3 Group n=2399 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 3.	Survey 4 Group n=3000 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 4.	Survey 5 Group n=5377 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 5.	Survey 6 Group n=5987 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 6.	Survey 7 Group n=7241 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 7.	Survey 8 Group n=7217 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 8.	Survey 9 Group n=7203 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 9.	Survey 10 Group n=7202 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 10.
Number of Participants Using Malaria Control Interventions: Bednet Usage and Type of Bednet New bednet [less than 1 year]	2524 Participants	2081 Participants	1552 Participants	1843 Participants	2897 Participants	2292 Participants	3829 Participants	4086 Participants	2986 Participants	3889 Participants
Number of Participants Using Malaria Control Interventions: Bednet Usage and Type of Bednet Pierced/torn Bednet	906 Participants	872 Participants	431 Participants	500 Participants	1805 Participants	2142 Participants	1874 Participants	2017 Participants	2487 Participants	1761 Participants
Number of Participants Using Malaria Control Interventions: Bednet Usage and Type of Bednet How many holes of size, Less than 5	435 Participants	347 Participants	261 Participants	398 Participants	1271 Participants	1427 Participants	1255 Participants	1455 Participants	1791 Participants	1189 Participants
Number of Participants Using Malaria Control Interventions: Bednet Usage and Type of Bednet How many holes of size, More or equal to 5	471 Participants	525 Participants	170 Participants	102 Participants	534 Participants	715 Participants	619 Participants	562 Participants	696 Participants	572 Participants
Number of Participants Using Malaria Control Interventions: Bednet Usage and Type of Bednet How many holes of size, NA	3302 Participants	3327 Participants	1968 Participants	2500 Participants	3572 Participants	3845 Participants	5366 Participants	5200 Participants	4716 Participants	5441 Participants
Number of Participants Using Malaria Control Interventions: Bednet Usage and Type of Bednet Participant sleep under a mosquito net night before visit	3768 Participants	3628 Participants	2152 Participants	2733 Participants	4805 Participants	5140 Participants	6281 Participants	6312 Participants	6125 Participants	6161 Participants
Number of Participants Using Malaria Control Interventions: Bednet Usage and Type of Bednet Impregnated [dipped in liquid to repel mosquitos after purchase] Bednet	2590 Participants	2825 Participants	1359 Participants	2457 Participants	4201 Participants	4458 Participants	5623 Participants	5343 Participants	5397 Participants	5449 Participants
Number of Participants Using Malaria Control Interventions: Bednet Usage and Type of Bednet How many holes of size, MC	—	—	—	—	—	—	1 Participants	—	—	—

PRIMARY outcome

Timeframe: At Day 1 (survey completion visit)

The number of participants using malaria control interventions was summarized by: mosquito coils, insecticide sprays, commercial repellants, traditional repellants and indoor residual sprays (in the past 12 months, 1 to 12 months, NA \[the participant didn't use the residual spray\], missing \[participant used spray but didn't answer to how long ago\]).

Outcome measures

Outcome measures
Measure	Survey 1 Group n=4208 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 1.	Survey 2 Group n=4199 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 2.	Survey 3 Group n=2399 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 3.	Survey 4 Group n=3000 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 4.	Survey 5 Group n=5377 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 5.	Survey 6 Group n=5987 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 6.	Survey 7 Group n=7241 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 7.	Survey 8 Group n=7217 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 8.	Survey 9 Group n=7203 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 9.	Survey 10 Group n=7202 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 10.
Number of Participants Using Malaria Control Interventions: Mosquito Coils, Insecticide Sprays, Commercial Repellants, Traditional Repellants and Indoor Residual Sprays Use of IRS, NA	3908 Participants	4175 Participants	2394 Participants	2721 Participants	5084 Participants	4238 Participants	5444 Participants	5398 Participants	5221 Participants	5270 Participants
Number of Participants Using Malaria Control Interventions: Mosquito Coils, Insecticide Sprays, Commercial Repellants, Traditional Repellants and Indoor Residual Sprays Use of IRS 4 month ago	1 Participants	1 Participants	0 Participants	1 Participants	58 Participants	134 Participants	102 Participants	59 Participants	248 Participants	179 Participants
Number of Participants Using Malaria Control Interventions: Mosquito Coils, Insecticide Sprays, Commercial Repellants, Traditional Repellants and Indoor Residual Sprays Use of Mosquito coils	246 Participants	305 Participants	150 Participants	359 Participants	452 Participants	808 Participants	1137 Participants	1205 Participants	1379 Participants	1514 Participants
Number of Participants Using Malaria Control Interventions: Mosquito Coils, Insecticide Sprays, Commercial Repellants, Traditional Repellants and Indoor Residual Sprays Use of Insecticide sprays	52 Participants	65 Participants	44 Participants	118 Participants	119 Participants	230 Participants	265 Participants	325 Participants	253 Participants	247 Participants
Number of Participants Using Malaria Control Interventions: Mosquito Coils, Insecticide Sprays, Commercial Repellants, Traditional Repellants and Indoor Residual Sprays Use of Commercial Repellents	56 Participants	22 Participants	14 Participants	19 Participants	22 Participants	50 Participants	68 Participants	114 Participants	103 Participants	60 Participants
Number of Participants Using Malaria Control Interventions: Mosquito Coils, Insecticide Sprays, Commercial Repellants, Traditional Repellants and Indoor Residual Sprays Use of Traditional Repellents	122 Participants	106 Participants	1 Participants	8 Participants	103 Participants	28 Participants	134 Participants	74 Participants	149 Participants	108 Participants
Number of Participants Using Malaria Control Interventions: Mosquito Coils, Insecticide Sprays, Commercial Repellants, Traditional Repellants and Indoor Residual Sprays Use of indoor residual spray (IRS) in past 12 months	300 Participants	42 Participants	5 Participants	279 Participants	293 Participants	1749 Participants	1797 Participants	1819 Participants	1978 Participants	1932 Participants
Number of Participants Using Malaria Control Interventions: Mosquito Coils, Insecticide Sprays, Commercial Repellants, Traditional Repellants and Indoor Residual Sprays Use of IRS 1 month ago	1 Participants	15 Participants	1 Participants	208 Participants	17 Participants	21 Participants	1 Participants	18 Participants	35 Participants	8 Participants
Number of Participants Using Malaria Control Interventions: Mosquito Coils, Insecticide Sprays, Commercial Repellants, Traditional Repellants and Indoor Residual Sprays Use of IRS 2 month ago	161 Participants	7 Participants	2 Participants	38 Participants	20 Participants	14 Participants	5 Participants	7 Participants	51 Participants	17 Participants
Number of Participants Using Malaria Control Interventions: Mosquito Coils, Insecticide Sprays, Commercial Repellants, Traditional Repellants and Indoor Residual Sprays Use of IRS 3 month ago	124 Participants	8 Participants	0 Participants	13 Participants	35 Participants	45 Participants	45 Participants	52 Participants	155 Participants	98 Participants
Number of Participants Using Malaria Control Interventions: Mosquito Coils, Insecticide Sprays, Commercial Repellants, Traditional Repellants and Indoor Residual Sprays Use of IRS 5 month ago	0 Participants	0 Participants	1 Participants	4 Participants	69 Participants	274 Participants	420 Participants	187 Participants	338 Participants	222 Participants
Number of Participants Using Malaria Control Interventions: Mosquito Coils, Insecticide Sprays, Commercial Repellants, Traditional Repellants and Indoor Residual Sprays Use of IRS 8 month ago	1 Participants	1 Participants	0 Participants	0 Participants	13 Participants	330 Participants	33 Participants	309 Participants	187 Participants	773 Participants
Number of Participants Using Malaria Control Interventions: Mosquito Coils, Insecticide Sprays, Commercial Repellants, Traditional Repellants and Indoor Residual Sprays Use of IRS 10 month ago	0 Participants	0 Participants	0 Participants	0 Participants	3 Participants	1 Participants	1 Participants	1 Participants	10 Participants	0 Participants
Number of Participants Using Malaria Control Interventions: Mosquito Coils, Insecticide Sprays, Commercial Repellants, Traditional Repellants and Indoor Residual Sprays Use of IRS 12 month ago	0 Participants	2 Participants	0 Participants	11 Participants	5 Participants	2 Participants	5 Participants	3 Participants	1 Participants	0 Participants
Number of Participants Using Malaria Control Interventions: Mosquito Coils, Insecticide Sprays, Commercial Repellants, Traditional Repellants and Indoor Residual Sprays Missing	—	—	—	—	2 Participants	—	—	—	4 Participants	—
Number of Participants Using Malaria Control Interventions: Mosquito Coils, Insecticide Sprays, Commercial Repellants, Traditional Repellants and Indoor Residual Sprays Use of IRS 6 month ago	2 Participants	0 Participants	0 Participants	4 Participants	44 Participants	452 Participants	665 Participants	557 Participants	434 Participants	148 Participants
Number of Participants Using Malaria Control Interventions: Mosquito Coils, Insecticide Sprays, Commercial Repellants, Traditional Repellants and Indoor Residual Sprays Use of IRS 7 month ago	0 Participants	0 Participants	0 Participants	0 Participants	17 Participants	359 Participants	519 Participants	555 Participants	443 Participants	407 Participants
Number of Participants Using Malaria Control Interventions: Mosquito Coils, Insecticide Sprays, Commercial Repellants, Traditional Repellants and Indoor Residual Sprays Use of IRS 9 month ago	10 Participants	5 Participants	1 Participants	0 Participants	7 Participants	114 Participants	1 Participants	64 Participants	75 Participants	75 Participants
Number of Participants Using Malaria Control Interventions: Mosquito Coils, Insecticide Sprays, Commercial Repellants, Traditional Repellants and Indoor Residual Sprays Use of IRS 11 month ago	0 Participants	3 Participants	0 Participants	0 Participants	3 Participants	3 Participants	0 Participants	7 Participants	1 Participants	5 Participants

SECONDARY outcome

Timeframe: At Day 1 (survey completion visit)

The number of participants was summarized by: center number/ country \[BF, SN, TZ, KE, GH, MA\]/ city, gender (female, male) and infection status (infected, not infected).

Outcome measures

Outcome measures
Measure	Survey 1 Group n=606 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 1.	Survey 2 Group n=601 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 2.	Survey 3 Group n=600 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 3.	Survey 4 Group n=600 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 4.	Survey 5 Group n=611 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 5.	Survey 6 Group n=602 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 6.	Survey 7 Group n=621 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 7.	Survey 8 Group n=606 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 8.	Survey 9 Group n=603 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 9.	Survey 10 Group n=603 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 10.
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 235578_KE_Bondo · Female, Not infected	—	—	—	—	206 Participants	206 Participants	251 Participants	262 Participants	247 Participants	270 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 235578_KE_Gem · Male, Infected	—	—	—	—	78 Participants	69 Participants	56 Participants	55 Participants	53 Participants	45 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 233150_MA_Chikwawa · Male, Infected	—	—	—	—	34 Participants	—	51 Participants	18 Participants	12 Participants	18 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 233150_MA_Chikwawa · Male, Not infected	—	—	—	—	237 Participants	—	252 Participants	294 Participants	281 Participants	312 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 235578_KE_Bondo · Male, Infected	—	—	—	—	91 Participants	92 Participants	80 Participants	67 Participants	48 Participants	44 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 235579_KE_Nyando · Male, Not infected	—	—	—	—	—	227 Participants	253 Participants	267 Participants	243 Participants	239 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 235579_KE_Nyando · Female, Not infected	—	—	—	—	—	220 Participants	240 Participants	265 Participants	263 Participants	272 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207078_BF_Nouna · Female, Infected	204 Participants	237 Participants	180 Participants	125 Participants	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207078_BF_Nouna · Male, Not infected	103 Participants	49 Participants	120 Participants	188 Participants	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207083_GH_Kintampo_EXP · Male, Not infected	—	—	186 Participants	213 Participants	240 Participants	249 Participants	243 Participants	256 Participants	258 Participants	285 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207082_KE_Kombewa · Male, Infected	106 Participants	95 Participants	111 Participants	105 Participants	101 Participants	89 Participants	68 Participants	67 Participants	80 Participants	54 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207078_BF_Nouna · Male, Infected	199 Participants	251 Participants	172 Participants	132 Participants	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207082_KE_Kombewa · Female, Infected	90 Participants	94 Participants	102 Participants	106 Participants	86 Participants	96 Participants	66 Participants	56 Participants	44 Participants	64 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207082_KE_Kombewa · Male, Not infected	214 Participants	189 Participants	177 Participants	186 Participants	216 Participants	199 Participants	220 Participants	221 Participants	242 Participants	232 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207082_KE_Kombewa · Female, Not infected	189 Participants	221 Participants	209 Participants	203 Participants	197 Participants	216 Participants	246 Participants	256 Participants	234 Participants	250 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207083_GH_Kintampo · Male, Infected	118 Participants	111 Participants	—	—	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207083_GH_Kintampo · Female, Infected	96 Participants	101 Participants	—	—	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207083_GH_Kintampo · Male, Not infected	204 Participants	192 Participants	—	—	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207083_GH_Kintampo · Female, Not infected	182 Participants	196 Participants	—	—	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207083_GH_Kintampo_EXP · Male, Infected	—	—	130 Participants	109 Participants	72 Participants	64 Participants	49 Participants	35 Participants	28 Participants	28 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207083_GH_Kintampo_EXP · Female, Infected	—	—	95 Participants	77 Participants	81 Participants	55 Participants	54 Participants	39 Participants	35 Participants	24 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207078_BF_Nouna · Female, Not infected	100 Participants	63 Participants	128 Participants	155 Participants	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207083_GH_Kintampo_EXP · Female, Not infected	—	—	189 Participants	201 Participants	207 Participants	232 Participants	254 Participants	270 Participants	279 Participants	263 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207079_BF_Sapone · Male, Infected	160 Participants	162 Participants	108 Participants	108 Participants	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207079_BF_Sapone · Female, Infected	139 Participants	154 Participants	86 Participants	96 Participants	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207079_BF_Sapone · Male, Not infected	149 Participants	154 Participants	204 Participants	200 Participants	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207079_BF_Sapone · Female, Not infected	156 Participants	129 Participants	202 Participants	196 Participants	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207080_SN_Niakhar · Male, Infected	4 Participants	2 Participants	—	—	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207080_SN_Niakhar · Female, Infected	5 Participants	1 Participants	—	—	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207080_SN_Niakhar · Male, Not infected	285 Participants	319 Participants	—	—	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207080_SN_Niakhar · Female, Not infected	304 Participants	279 Participants	—	—	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207081_TZ_Korogwe · Male, Infected	32 Participants	9 Participants	—	—	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207081_TZ_Korogwe · Female, Infected	31 Participants	9 Participants	—	—	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207081_TZ_Korogwe · Male, Not infected	287 Participants	285 Participants	—	—	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207081_TZ_Korogwe · Female, Not infected	251 Participants	297 Participants	—	—	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207083_GH_Kintampo_UNEXP · Male, Infected	—	—	—	—	—	86 Participants	63 Participants	47 Participants	48 Participants	37 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 233149_MA_Mangochi · Male, Not infected	—	—	—	—	226 Participants	243 Participants	274 Participants	244 Participants	272 Participants	253 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207083_GH_Kintampo_UNEXP · Female, Infected	—	—	—	—	—	69 Participants	70 Participants	52 Participants	43 Participants	30 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207083_GH_Kintampo_UNEXP · Male, Not infected	—	—	—	—	—	215 Participants	227 Participants	253 Participants	276 Participants	285 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207083_GH_Kintampo_UNEXP · Female, Not infected	—	—	—	—	—	230 Participants	240 Participants	248 Participants	233 Participants	248 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207084_SN_Keur Soce · Male, Infected	1 Participants	5 Participants	—	—	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207084_SN_Keur Soce · Female, Infected	2 Participants	1 Participants	—	—	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207084_SN_Keur Soce · Male, Not infected	296 Participants	288 Participants	—	—	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 207084_SN_Keur Soce · Female, Not infected	301 Participants	306 Participants	—	—	—	—	—	—	—	—
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 228607_GH_Navrongo_EXP · Male, Infected	—	—	—	57 Participants	56 Participants	50 Participants	46 Participants	29 Participants	33 Participants	37 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 228607_GH_Navrongo_EXP · Female, Infected	—	—	—	43 Participants	54 Participants	47 Participants	31 Participants	40 Participants	41 Participants	37 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 228607_GH_Navrongo_EXP · Male, Not infected	—	—	—	256 Participants	266 Participants	257 Participants	253 Participants	268 Participants	270 Participants	251 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 228607_GH_Navrongo_EXP · Female, Not infected	—	—	—	244 Participants	229 Participants	245 Participants	270 Participants	262 Participants	256 Participants	275 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 233149_MA_Mangochi · Female, Not infected	—	—	—	—	273 Participants	273 Participants	274 Participants	278 Participants	254 Participants	284 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 228607_GH_Navrongo_UNEXP · Male, Infected	—	—	—	—	—	49 Participants	56 Participants	43 Participants	50 Participants	46 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 233150_MA_Chikwawa · Female, Infected	—	—	—	—	35 Participants	—	46 Participants	14 Participants	5 Participants	7 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 233150_MA_Chikwawa · Female, Not infected	—	—	—	—	277 Participants	—	272 Participants	274 Participants	302 Participants	260 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 233149_MA_Monkey Bay · Male, Infected	—	—	—	—	33 Participants	19 Participants	15 Participants	19 Participants	20 Participants	22 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 228607_GH_Navrongo_UNEXP · Female, Infected	—	—	—	—	—	57 Participants	39 Participants	32 Participants	39 Participants	49 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 228607_GH_Navrongo_UNEXP · Male, Not infected	—	—	—	—	—	270 Participants	260 Participants	265 Participants	279 Participants	259 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 233149_MA_Monkey Bay · Female, Infected	—	—	—	—	30 Participants	16 Participants	19 Participants	19 Participants	24 Participants	26 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 233149_MA_Monkey Bay · Male, Not infected	—	—	—	—	281 Participants	272 Participants	296 Participants	253 Participants	286 Participants	276 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 233149_MA_Monkey Bay · Female, Not infected	—	—	—	—	254 Participants	293 Participants	270 Participants	309 Participants	269 Participants	275 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 233150_MA_St Monfort · Male, Infected	—	—	—	—	20 Participants	—	22 Participants	9 Participants	1 Participants	2 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 228607_GH_Navrongo_UNEXP · Female, Not infected	—	—	—	—	—	224 Participants	245 Participants	260 Participants	232 Participants	246 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 233150_MA_St Monfort · Female, Infected	—	—	—	—	18 Participants	—	31 Participants	5 Participants	1 Participants	2 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 233150_MA_St Monfort · Male, Not infected	—	—	—	—	277 Participants	—	288 Participants	284 Participants	332 Participants	303 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 233150_MA_St Monfort · Female, Not infected	—	—	—	—	269 Participants	—	272 Participants	302 Participants	266 Participants	296 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 233149_MA_Mangochi · Male, Infected	—	—	—	—	57 Participants	48 Participants	31 Participants	44 Participants	42 Participants	39 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 233149_MA_Mangochi · Female, Infected	—	—	—	—	41 Participants	38 Participants	20 Participants	34 Participants	33 Participants	25 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 235578_KE_Bondo · Female, Infected	—	—	—	—	67 Participants	87 Participants	59 Participants	60 Participants	57 Participants	42 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 235578_KE_Bondo · Male, Not infected	—	—	—	—	247 Participants	213 Participants	214 Participants	217 Participants	251 Participants	244 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 235578_KE_Gem · Female, Infected	—	—	—	—	68 Participants	62 Participants	59 Participants	51 Participants	57 Participants	43 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 235578_KE_Gem · Male, Not infected	—	—	—	—	221 Participants	226 Participants	248 Participants	260 Participants	236 Participants	254 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 235578_KE_Gem · Female, Not infected	—	—	—	—	232 Participants	231 Participants	241 Participants	240 Participants	254 Participants	260 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 235579_KE_Nyando · Male, Infected	—	—	—	—	—	88 Participants	51 Participants	42 Participants	57 Participants	44 Participants
Number of Participants Infected With P. Falciparum by Center, Gender and Infection Status 235579_KE_Nyando · Female, Infected	—	—	—	—	—	65 Participants	56 Participants	32 Participants	37 Participants	45 Participants

SECONDARY outcome

Timeframe: At Day 1 (survey completion visit)

The infections with other Plasmodium species were determined using a blood smear slide and microscopy. The number of participants infected with P. malaria, P. vivax and P. ovale was summarized.

Outcome measures

Outcome measures
Measure	Survey 1 Group n=4208 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 1.	Survey 2 Group n=4199 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 2.	Survey 3 Group n=2399 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 3.	Survey 4 Group n=3000 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 4.	Survey 5 Group n=5377 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 5.	Survey 6 Group n=5987 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 6.	Survey 7 Group n=7241 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 7.	Survey 8 Group n=7217 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 8.	Survey 9 Group n=7203 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 9.	Survey 10 Group n=7202 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 10.
Number of Participants Infected With Plasmodium Species Other Than P. Falciparum P. malaria	62 Participants	128 Participants	58 Participants	57 Participants	39 Participants	87 Participants	83 Participants	34 Participants	50 Participants	61 Participants
Number of Participants Infected With Plasmodium Species Other Than P. Falciparum P. vivax	0 Participants	1 Participants	8 Participants	0 Participants	0 Participants	0 Participants	1 Participants	0 Participants	0 Participants	0 Participants
Number of Participants Infected With Plasmodium Species Other Than P. Falciparum P. ovale	23 Participants	10 Participants	18 Participants	21 Participants	21 Participants	52 Participants	20 Participants	9 Participants	32 Participants	14 Participants

SECONDARY outcome

Timeframe: At Day 1 (survey completion visit)

Outcome measures

Outcome measures
Measure	Survey 1 Group n=4208 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 1.	Survey 2 Group n=4199 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 2.	Survey 3 Group n=2399 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 3.	Survey 4 Group n=3000 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 4.	Survey 5 Group n=5377 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 5.	Survey 6 Group n=5987 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 6.	Survey 7 Group n=7241 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 7.	Survey 8 Group n=7217 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 8.	Survey 9 Group n=7203 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 9.	Survey 10 Group n=7202 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 10.
Number of Participants Who Received Dose 3 of the Diphtheria, Tetanus, Pertussis/ Hepatitis B/ Haemophilus Influenzae Type b (DTP/HepB/Hib) Vaccine or Dose 1 of the Measles Vaccine DTP/HepB/Hib [3rd dose]	2922 Participants	3688 Participants	2029 Participants	2728 Participants	5165 Participants	5562 Participants	6745 Participants	6843 Participants	6856 Participants	6997 Participants
Number of Participants Who Received Dose 3 of the Diphtheria, Tetanus, Pertussis/ Hepatitis B/ Haemophilus Influenzae Type b (DTP/HepB/Hib) Vaccine or Dose 1 of the Measles Vaccine Measles [1st dose]	2261 Participants	3376 Participants	1897 Participants	2535 Participants	4787 Participants	5218 Participants	5435 Participants	6317 Participants	6340 Participants	6413 Participants

SECONDARY outcome

Timeframe: Up to 14 days prior to the study visit at Day 1

The number of participants who received anti-malarial therapy out of those who reported malaria in the last 14 days prior to the study visit was summarized.

Outcome measures

Outcome measures
Measure	Survey 1 Group n=4208 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 1.	Survey 2 Group n=4199 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 2.	Survey 3 Group n=2399 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 3.	Survey 4 Group n=3000 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 4.	Survey 5 Group n=1295 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 5.	Survey 6 Group n=5987 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 6.	Survey 7 Group n=7241 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 7.	Survey 8 Group n=7217 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 8.	Survey 9 Group n=7203 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 9.	Survey 10 Group n=7202 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 10.
Number of Participants Who Received Anti-malarial Therapy or Any Other Medication Within 14 Days Prior to the Study Visit	700 Participants	672 Participants	455 Participants	661 Participants	1295 Participants	1041 Participants	783 Participants	769 Participants	1043 Participants	516 Participants

SECONDARY outcome

Timeframe: At Day 1 (survey completion visit)

Fever was defined as an axillary temperature of 37.5°C or higher.

Outcome measures

Outcome measures
Measure	Survey 1 Group n=4208 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 1.	Survey 2 Group n=4199 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 2.	Survey 3 Group n=2399 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 3.	Survey 4 Group n=3000 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 4.	Survey 5 Group n=5377 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 5.	Survey 6 Group n=5987 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 6.	Survey 7 Group n=7241 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 7.	Survey 8 Group n=7217 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 8.	Survey 9 Group n=7203 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 9.	Survey 10 Group n=7202 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 10.
Number of Participants With Measured Fever at the Time of Their Study Visit	215 Participants	200 Participants	94 Participants	127 Participants	245 Participants	223 Participants	161 Participants	200 Participants	250 Participants	212 Participants

SECONDARY outcome

Timeframe: Up to 24 hours prior to their study visit at Day 1

Fever was defined as an axillary temperature of 37.5°C or higher.

Outcome measures

Outcome measures
Measure	Survey 1 Group n=4208 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 1.	Survey 2 Group n=4199 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 2.	Survey 3 Group n=2399 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 3.	Survey 4 Group n=3000 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 4.	Survey 5 Group n=5377 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 5.	Survey 6 Group n=5987 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 6.	Survey 7 Group n=7241 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 7.	Survey 8 Group n=7217 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 8.	Survey 9 Group n=7203 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 9.	Survey 10 Group n=7202 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 10.
Number of Participants With Reported Fever in the 24 Hours Prior to Their Study Visit	1060 Participants	1082 Participants	624 Participants	822 Participants	1307 Participants	1162 Participants	1133 Participants	1072 Participants	1235 Participants	1099 Participants

SECONDARY outcome

Timeframe: Up to 14 days prior to their study visit at Day 1

Population: The analysis was performed on the ATP Cohort which included all participants who met the eligibility criteria, adhered to the procedures defined in the protocol, had no elimination criteria during the study, had at least one laboratory result from a blood sample available and with usable data for the specified analysis for the specified time period. Here, 'number analyzed' = participants with available data for each specified row.

The number of participants demonstrating care-seeking behavior following reported fever or malaria was summarized by where the participant was taken for treatment (home, drug seller, pharmacy, private clinic, health center, hospital, other, not applicable \[no treatment received\]), by when the participant was taken for treatment (at onset, when the participant did not improve, when the participant got worse, other, not applicable \[no treatment received\], missing \[participant was taken for treatment but did not answer the question regarding when\]) and by what time the participant was taken for treatment (the same day, the next day, 2 days later, more than 2 days later, not applicable \[no treatment received\], missing \[participant was taken for treatment but did not answer the question regarding the time\]).

Outcome measures

Outcome measures
Measure	Survey 1 Group n=4208 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 1.	Survey 2 Group n=4199 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 2.	Survey 3 Group n=2399 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 3.	Survey 4 Group n=3000 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 4.	Survey 5 Group n=5377 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 5.	Survey 6 Group n=5987 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 6.	Survey 7 Group n=7241 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 7.	Survey 8 Group n=7217 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 8.	Survey 9 Group n=7203 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 9.	Survey 10 Group n=7202 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 10.
Number of Participants Demonstrating Care-seeking Behavior Following Reported Fever or Malaria up to 14 Days Prior to Their Study Visit Where the participant was taken for treatment - Private clinic	26 Participants	24 Participants	20 Participants	10 Participants	68 Participants	44 Participants	23 Participants	47 Participants	25 Participants	26 Participants
Number of Participants Demonstrating Care-seeking Behavior Following Reported Fever or Malaria up to 14 Days Prior to Their Study Visit Where the participant was taken for treatment - Health center	196 Participants	146 Participants	105 Participants	255 Participants	392 Participants	299 Participants	238 Participants	237 Participants	302 Participants	156 Participants
Number of Participants Demonstrating Care-seeking Behavior Following Reported Fever or Malaria up to 14 Days Prior to Their Study Visit Where the participant was taken for treatment - Hospital	40 Participants	40 Participants	31 Participants	46 Participants	77 Participants	67 Participants	53 Participants	66 Participants	50 Participants	26 Participants
Number of Participants Demonstrating Care-seeking Behavior Following Reported Fever or Malaria up to 14 Days Prior to Their Study Visit Where the participant was taken for treatment - Other	86 Participants	17 Participants	1 Participants	10 Participants	77 Participants	108 Participants	20 Participants	47 Participants	48 Participants	34 Participants
Number of Participants Demonstrating Care-seeking Behavior Following Reported Fever or Malaria up to 14 Days Prior to Their Study Visit Where the participant was taken for treatment - Not Applicable	3546 Participants	3662 Participants	2037 Participants	2429 Participants	4267 Participants	4977 Participants	6516 Participants	6509 Participants	6306 Participants	6700 Participants
Number of Participants Demonstrating Care-seeking Behavior Following Reported Fever or Malaria up to 14 Days Prior to Their Study Visit Where the participant was taken for treatment - Missing	6 Participants	—	—	5 Participants	3 Participants	2 Participants	2 Participants	—	—	—
Number of Participants Demonstrating Care-seeking Behavior Following Reported Fever or Malaria up to 14 Days Prior to Their Study Visit When the participant was taken for treatment - At onset	358 Participants	355 Participants	323 Participants	477 Participants	707 Participants	651 Participants	520 Participants	525 Participants	686 Participants	356 Participants
Number of Participants Demonstrating Care-seeking Behavior Following Reported Fever or Malaria up to 14 Days Prior to Their Study Visit When the participant was taken for treatment - When participant did not improve	33 Participants	23 Participants	29 Participants	86 Participants	346 Participants	263 Participants	178 Participants	145 Participants	159 Participants	118 Participants
Number of Participants Demonstrating Care-seeking Behavior Following Reported Fever or Malaria up to 14 Days Prior to Their Study Visit When the participant was taken for treatment - When participant got worse	11 Participants	5 Participants	7 Participants	7 Participants	43 Participants	92 Participants	26 Participants	35 Participants	52 Participants	28 Participants
Number of Participants Demonstrating Care-seeking Behavior Following Reported Fever or Malaria up to 14 Days Prior to Their Study Visit When the participant was taken for treatment - Other	49 Participants	1 Participants	0 Participants	0 Participants	5 Participants	1 Participants	0 Participants	1 Participants	0 Participants	0 Participants
Number of Participants Demonstrating Care-seeking Behavior Following Reported Fever or Malaria up to 14 Days Prior to Their Study Visit When the participant was taken for treatment - Not Applicable	3546 Participants	3662 Participants	2037 Participants	2429 Participants	4267 Participants	4977 Participants	6516 Participants	6509 Participants	6306 Participants	6700 Participants
Number of Participants Demonstrating Care-seeking Behavior Following Reported Fever or Malaria up to 14 Days Prior to Their Study Visit What time the participant was taken for treatment - Same day	300 Participants	278 Participants	213 Participants	416 Participants	707 Participants	610 Participants	473 Participants	464 Participants	596 Participants	310 Participants
Number of Participants Demonstrating Care-seeking Behavior Following Reported Fever or Malaria up to 14 Days Prior to Their Study Visit What time the participant was taken for treatment - Two days later	28 Participants	11 Participants	17 Participants	17 Participants	43 Participants	71 Participants	53 Participants	43 Participants	38 Participants	29 Participants
Number of Participants Demonstrating Care-seeking Behavior Following Reported Fever or Malaria up to 14 Days Prior to Their Study Visit What time the participant was taken for treatment - Missing	246 Participants	154 Participants	2 Participants	5 Participants	17 Participants	6 Participants	2 Participants	3 Participants	1 Participants	—
Number of Participants Demonstrating Care-seeking Behavior Following Reported Fever or Malaria up to 14 Days Prior to Their Study Visit Where the participant was taken for treatment - Home	117 Participants	102 Participants	42 Participants	88 Participants	209 Participants	194 Participants	130 Participants	94 Participants	208 Participants	110 Participants
Number of Participants Demonstrating Care-seeking Behavior Following Reported Fever or Malaria up to 14 Days Prior to Their Study Visit Where the participant was taken for treatment - Pharmacy	97 Participants	45 Participants	11 Participants	48 Participants	135 Participants	124 Participants	101 Participants	106 Participants	111 Participants	73 Participants
Number of Participants Demonstrating Care-seeking Behavior Following Reported Fever or Malaria up to 14 Days Prior to Their Study Visit Where the participant was taken for treatment - Drug seller	94 Participants	163 Participants	152 Participants	109 Participants	149 Participants	172 Participants	158 Participants	111 Participants	153 Participants	77 Participants
Number of Participants Demonstrating Care-seeking Behavior Following Reported Fever or Malaria up to 14 Days Prior to Their Study Visit What time the participant was taken for treatment - Next day	59 Participants	83 Participants	121 Participants	127 Participants	346 Participants	258 Participants	177 Participants	172 Participants	239 Participants	151 Participants
Number of Participants Demonstrating Care-seeking Behavior Following Reported Fever or Malaria up to 14 Days Prior to Their Study Visit When the participant was taken for treatment - Missing	211 Participants	153 Participants	3 Participants	1 Participants	3 Participants	3 Participants	1 Participants	2 Participants	—	—
Number of Participants Demonstrating Care-seeking Behavior Following Reported Fever or Malaria up to 14 Days Prior to Their Study Visit What time the participant was taken for treatment - More than 2 days later	29 Participants	11 Participants	9 Participants	6 Participants	5 Participants	65 Participants	20 Participants	26 Participants	23 Participants	12 Participants
Number of Participants Demonstrating Care-seeking Behavior Following Reported Fever or Malaria up to 14 Days Prior to Their Study Visit What time the participant was taken for treatment - Not Applicable	3546 Participants	3662 Participants	2037 Participants	2429 Participants	4267 Participants	4977 Participants	6516 Participants	6509 Participants	6306 Participants	6700 Participants

SECONDARY outcome

Timeframe: At Day 1 (survey completion visit)

The number of participants was summarized by: center number/ country \[BF, SN, TZ, KE, GH, MA\]/ city followed by the segment ID. Positioning of the participant's residence was attributed to a segment with a unique ID from the grid referencing study area map in which the participant resided; where necessary, grouping small geographically proximate villages so that each segment had at least 10 study participants to avoid personally identifiable information (PII), and proceeding as far as geographically appropriate.

Outcome measures

Outcome measures
Measure	Survey 1 Group n=606 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 1.	Survey 2 Group n=601 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 2.	Survey 3 Group n=600 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 3.	Survey 4 Group n=600 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 4.	Survey 5 Group n=611 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 5.	Survey 6 Group n=602 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 6.	Survey 7 Group n=621 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 7.	Survey 8 Group n=606 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 8.	Survey 9 Group n=603 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 9.	Survey 10 Group n=603 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 10.
Number of Participants in Each Geo-referenced Segment 233150_MA_Chikwawa, ID-23315008	—	—	—	—	117 Participants	—	55 Participants	225 Participants	228 Participants	228 Participants
Number of Participants in Each Geo-referenced Segment 233150_MA_Chikwawa, ID-23315010	—	—	—	—	292 Participants	—	346 Participants	156 Participants	289 Participants	246 Participants
Number of Participants in Each Geo-referenced Segment 233150_MA_Chikwawa, ID-23315011	—	—	—	—	42 Participants	—	42 Participants	88 Participants	21 Participants	69 Participants
Number of Participants in Each Geo-referenced Segment 207078_BF_Nouna, ID-20707863	38 Participants	26 Participants	37 Participants	27 Participants	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207078_BF_Nouna, ID-20707865	39 Participants	45 Participants	48 Participants	53 Participants	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207078_BF_Nouna, ID-20707866	38 Participants	233 Participants	51 Participants	27 Participants	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207078_BF_Nouna, ID-20707867	23 Participants	27 Participants	22 Participants	34 Participants	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207078_BF_Nouna, ID-20707868	218 Participants	42 Participants	178 Participants	172 Participants	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207078_BF_Nouna, ID-20707869	18 Participants	—	16 Participants	24 Participants	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207078_BF_Nouna, ID-20707870	23 Participants	—	40 Participants	22 Participants	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207079_BF_Sapone, ID-1	57 Participants	51 Participants	69 Participants	70 Participants	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207079_BF_Sapone, ID-10	65 Participants	69 Participants	64 Participants	52 Participants	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207079_BF_Sapone, ID-11	34 Participants	25 Participants	25 Participants	19 Participants	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207079_BF_Sapone, ID-2	45 Participants	41 Participants	41 Participants	37 Participants	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207079_BF_Sapone, ID-5	47 Participants	45 Participants	38 Participants	45 Participants	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207080_SN_Niakhar, ID-3	50 Participants	54 Participants	—	—	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207080_SN_Niakhar, ID-6	19 Participants	19 Participants	—	—	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207080_SN_Niakhar, ID-7	104 Participants	75 Participants	—	—	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207080_SN_Niakhar, ID-9	92 Participants	83 Participants	—	—	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207083_GH_Kintampo_EXP, ID-2	—	—	242 Participants	207 Participants	213 Participants	160 Participants	214 Participants	246 Participants	180 Participants	167 Participants
Number of Participants in Each Geo-referenced Segment 207083_GH_Kintampo_UNEXP, ID-2070831	—	—	—	—	—	130 Participants	130 Participants	151 Participants	164 Participants	179 Participants
Number of Participants in Each Geo-referenced Segment 207083_GH_Kintampo_UNEXP, ID-2070832	—	—	—	—	—	296 Participants	287 Participants	268 Participants	269 Participants	229 Participants
Number of Participants in Each Geo-referenced Segment 228607_GH_Navrongo_EXP, ID-2286071	—	—	—	41 Participants	56 Participants	78 Participants	94 Participants	55 Participants	39 Participants	124 Participants
Number of Participants in Each Geo-referenced Segment 228607_GH_Navrongo_EXP, ID-22860705	—	—	—	—	—	10 Participants	—	—	—	—
Number of Participants in Each Geo-referenced Segment 228607_GH_Navrongo_UNEXP, ID-2286071	—	—	—	—	—	10 Participants	9 Participants	11 Participants	9 Participants	13 Participants
Number of Participants in Each Geo-referenced Segment 228607_GH_Navrongo_UNEXP, ID-22860714	—	—	—	—	—	3 Participants	3 Participants	2 Participants	20 Participants	7 Participants
Number of Participants in Each Geo-referenced Segment 233149_MA_Mangochi, ID-23314913	—	—	—	—	214 Participants	102 Participants	113 Participants	125 Participants	177 Participants	92 Participants
Number of Participants in Each Geo-referenced Segment 233149_MA_Monkey Bay, ID-23314912	—	—	—	—	1 Participants	—	—	—	—	3 Participants
Number of Participants in Each Geo-referenced Segment 233150_MA_St Monfort, ID-23315010	—	—	—	—	—	—	1 Participants	—	—	2 Participants
Number of Participants in Each Geo-referenced Segment 235578_KE_Bondo, ID-23557802	—	—	—	—	85 Participants	131 Participants	128 Participants	145 Participants	123 Participants	137 Participants
Number of Participants in Each Geo-referenced Segment 235578_KE_Bondo, ID-23557803	—	—	—	—	147 Participants	99 Participants	113 Participants	110 Participants	105 Participants	106 Participants
Number of Participants in Each Geo-referenced Segment 235578_KE_Bondo, ID-23557805	—	—	—	—	101 Participants	79 Participants	96 Participants	79 Participants	88 Participants	92 Participants
Number of Participants in Each Geo-referenced Segment 235578_KE_Bondo, ID-23557806	—	—	—	—	55 Participants	146 Participants	99 Participants	86 Participants	99 Participants	84 Participants
Number of Participants in Each Geo-referenced Segment 235578_KE_Gem, ID-23557801	—	—	—	—	86 Participants	135 Participants	108 Participants	88 Participants	92 Participants	116 Participants
Number of Participants in Each Geo-referenced Segment 235578_KE_Gem, ID-23557803	—	—	—	—	141 Participants	73 Participants	106 Participants	114 Participants	104 Participants	122 Participants
Number of Participants in Each Geo-referenced Segment 235578_KE_Gem, ID-23557805	—	—	—	—	88 Participants	197 Participants	135 Participants	107 Participants	86 Participants	79 Participants
Number of Participants in Each Geo-referenced Segment 235579_KE_Nyando, ID-23557914	—	—	—	—	—	23 Participants	19 Participants	34 Participants	39 Participants	75 Participants
Number of Participants in Each Geo-referenced Segment 235579_KE_Nyando, ID-23557928	—	—	—	—	—	59 Participants	28 Participants	61 Participants	35 Participants	—
Number of Participants in Each Geo-referenced Segment 207082_KE_Kombewa, ID-13	82 Participants	68 Participants	58 Participants	69 Participants	82 Participants	57 Participants	63 Participants	59 Participants	148 Participants	85 Participants
Number of Participants in Each Geo-referenced Segment 207078_BF_Nouna, ID-20707860	21 Participants	58 Participants	11 Participants	30 Participants	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207078_BF_Nouna, ID-20707861	50 Participants	66 Participants	55 Participants	38 Participants	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207078_BF_Nouna, ID-20707862	21 Participants	26 Participants	20 Participants	31 Participants	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207078_BF_Nouna, ID-20707864	27 Participants	77 Participants	39 Participants	33 Participants	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207082_KE_Kombewa, ID-14	54 Participants	29 Participants	44 Participants	57 Participants	45 Participants	39 Participants	67 Participants	30 Participants	61 Participants	49 Participants
Number of Participants in Each Geo-referenced Segment 207078_BF_Nouna, ID-20707871	30 Participants	—	25 Participants	39 Participants	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207078_BF_Nouna, ID-20707872	28 Participants	—	40 Participants	44 Participants	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207078_BF_Nouna, ID-20707873	32 Participants	—	18 Participants	26 Participants	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207079_BF_Sapone, ID-12	13 Participants	34 Participants	28 Participants	40 Participants	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207079_BF_Sapone, ID-13	29 Participants	48 Participants	46 Participants	43 Participants	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207079_BF_Sapone, ID-14	15 Participants	26 Participants	32 Participants	33 Participants	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207079_BF_Sapone, ID-3	42 Participants	39 Participants	53 Participants	58 Participants	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207079_BF_Sapone, ID-4	59 Participants	48 Participants	57 Participants	67 Participants	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207083_GH_Kintampo_EXP, ID-1	—	—	188 Participants	250 Participants	248 Participants	359 Participants	276 Participants	266 Participants	335 Participants	299 Participants
Number of Participants in Each Geo-referenced Segment 207079_BF_Sapone, ID-6	40 Participants	49 Participants	41 Participants	34 Participants	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207079_BF_Sapone, ID-7	45 Participants	36 Participants	34 Participants	28 Participants	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207081_TZ_Korogwe, ID-4	132 Participants	138 Participants	—	—	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207079_BF_Sapone, ID-8	78 Participants	51 Participants	44 Participants	53 Participants	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207079_BF_Sapone, ID-9	35 Participants	37 Participants	28 Participants	21 Participants	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207080_SN_Niakhar, ID-1	32 Participants	51 Participants	—	—	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207080_SN_Niakhar, ID-2	69 Participants	106 Participants	—	—	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207080_SN_Niakhar, ID-4	49 Participants	33 Participants	—	—	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207080_SN_Niakhar, ID-5	89 Participants	93 Participants	—	—	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207080_SN_Niakhar, ID-8	94 Participants	87 Participants	—	—	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207081_TZ_Korogwe, ID-1	17 Participants	27 Participants	—	—	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207081_TZ_Korogwe, ID-2	135 Participants	130 Participants	—	—	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207081_TZ_Korogwe, ID-3	83 Participants	108 Participants	—	—	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207081_TZ_Korogwe, ID-5	42 Participants	42 Participants	—	—	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207081_TZ_Korogwe, ID-6	77 Participants	61 Participants	—	—	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207081_TZ_Korogwe, ID-7	115 Participants	94 Participants	—	—	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207082_KE_Kombewa, ID-11	140 Participants	75 Participants	133 Participants	129 Participants	133 Participants	120 Participants	118 Participants	112 Participants	79 Participants	146 Participants
Number of Participants in Each Geo-referenced Segment 233149_MA_Monkey Bay, ID-23314922	—	—	—	—	446 Participants	410 Participants	443 Participants	421 Participants	360 Participants	355 Participants
Number of Participants in Each Geo-referenced Segment 207082_KE_Kombewa, ID-12	31 Participants	52 Participants	48 Participants	47 Participants	42 Participants	66 Participants	51 Participants	66 Participants	89 Participants	54 Participants
Number of Participants in Each Geo-referenced Segment 233149_MA_Monkey Bay, ID-23314913	—	—	—	—	—	5 Participants	—	—	—	—
Number of Participants in Each Geo-referenced Segment 233150_MA_Chikwawa, ID-23315006	—	—	—	—	39 Participants	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 233150_MA_Chikwawa, ID-23315007	—	—	—	—	53 Participants	—	92 Participants	112 Participants	57 Participants	52 Participants
Number of Participants in Each Geo-referenced Segment 207082_KE_Kombewa, ID-21	58 Participants	75 Participants	65 Participants	100 Participants	68 Participants	68 Participants	90 Participants	79 Participants	57 Participants	71 Participants
Number of Participants in Each Geo-referenced Segment 207082_KE_Kombewa, ID-22	91 Participants	124 Participants	109 Participants	68 Participants	83 Participants	79 Participants	34 Participants	51 Participants	8 Participants	77 Participants
Number of Participants in Each Geo-referenced Segment 207082_KE_Kombewa, ID-23	54 Participants	104 Participants	74 Participants	54 Participants	65 Participants	70 Participants	65 Participants	126 Participants	72 Participants	59 Participants
Number of Participants in Each Geo-referenced Segment 207082_KE_Kombewa, ID-24	89 Participants	72 Participants	68 Participants	76 Participants	82 Participants	101 Participants	112 Participants	77 Participants	86 Participants	59 Participants
Number of Participants in Each Geo-referenced Segment 207083_GH_Kintampo, ID-1	163 Participants	158 Participants	—	—	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207083_GH_Kintampo, ID-2	257 Participants	168 Participants	—	—	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207083_GH_Kintampo, ID-3	180 Participants	274 Participants	—	—	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207084_SN_Keur Soce, ID-1	148 Participants	139 Participants	—	—	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207084_SN_Keur Soce, ID-2	243 Participants	269 Participants	—	—	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207084_SN_Keur Soce, ID-3	142 Participants	136 Participants	—	—	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207084_SN_Keur Soce, ID-4	67 Participants	56 Participants	—	—	—	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 207083_GH_Kintampo_EXP, ID-3	—	—	170 Participants	143 Participants	139 Participants	81 Participants	110 Participants	88 Participants	85 Participants	134 Participants
Number of Participants in Each Geo-referenced Segment 207083_GH_Kintampo_UNEXP, ID-2070833	—	—	—	—	—	174 Participants	183 Participants	181 Participants	167 Participants	192 Participants
Number of Participants in Each Geo-referenced Segment 228607_GH_Navrongo_UNEXP, ID-22860710	—	—	—	—	—	52 Participants	29 Participants	18 Participants	38 Participants	43 Participants
Number of Participants in Each Geo-referenced Segment 228607_GH_Navrongo_EXP, ID-2286072	—	—	—	110 Participants	133 Participants	124 Participants	88 Participants	103 Participants	120 Participants	136 Participants
Number of Participants in Each Geo-referenced Segment 228607_GH_Navrongo_EXP, ID-2286073	—	—	—	127 Participants	108 Participants	125 Participants	118 Participants	162 Participants	124 Participants	162 Participants
Number of Participants in Each Geo-referenced Segment 228607_GH_Navrongo_EXP, ID-2286074	—	—	—	188 Participants	190 Participants	168 Participants	191 Participants	172 Participants	224 Participants	83 Participants
Number of Participants in Each Geo-referenced Segment 228607_GH_Navrongo_EXP, ID-2286075	—	—	—	134 Participants	118 Participants	93 Participants	109 Participants	107 Participants	93 Participants	95 Participants
Number of Participants in Each Geo-referenced Segment 228607_GH_Navrongo_EXP, ID-22860712	—	—	—	—	—	124 Participants	—	—	—	—
Number of Participants in Each Geo-referenced Segment 228607_GH_Navrongo_UNEXP, ID-22860709	—	—	—	—	—	8 Participants	—	—	—	—
Number of Participants in Each Geo-referenced Segment 228607_GH_Navrongo_UNEXP, ID-22860711	—	—	—	—	—	32 Participants	33 Participants	22 Participants	41 Participants	36 Participants
Number of Participants in Each Geo-referenced Segment 228607_GH_Navrongo_UNEXP, ID-22860712	—	—	—	—	—	89 Participants	90 Participants	80 Participants	75 Participants	75 Participants
Number of Participants in Each Geo-referenced Segment 228607_GH_Navrongo_UNEXP, ID-22860713	—	—	—	—	—	15 Participants	12 Participants	2 Participants	12 Participants	7 Participants
Number of Participants in Each Geo-referenced Segment 228607_GH_Navrongo_UNEXP, ID-2286072	—	—	—	—	—	66 Participants	70 Participants	67 Participants	70 Participants	63 Participants
Number of Participants in Each Geo-referenced Segment 228607_GH_Navrongo_UNEXP, ID-2286073	—	—	—	—	—	18 Participants	18 Participants	14 Participants	11 Participants	18 Participants
Number of Participants in Each Geo-referenced Segment 228607_GH_Navrongo_UNEXP, ID-2286074	—	—	—	—	—	80 Participants	91 Participants	82 Participants	104 Participants	84 Participants
Number of Participants in Each Geo-referenced Segment 228607_GH_Navrongo_UNEXP, ID-2286075	—	—	—	—	—	12 Participants	9 Participants	9 Participants	6 Participants	9 Participants
Number of Participants in Each Geo-referenced Segment 228607_GH_Navrongo_UNEXP, ID-2286076	—	—	—	—	—	12 Participants	38 Participants	46 Participants	37 Participants	25 Participants
Number of Participants in Each Geo-referenced Segment 228607_GH_Navrongo_UNEXP, ID-2286077	—	—	—	—	—	46 Participants	43 Participants	39 Participants	48 Participants	39 Participants
Number of Participants in Each Geo-referenced Segment 228607_GH_Navrongo_UNEXP, ID-2286078	—	—	—	—	—	60 Participants	53 Participants	77 Participants	26 Participants	50 Participants
Number of Participants in Each Geo-referenced Segment 228607_GH_Navrongo_UNEXP, ID-2286079	—	—	—	—	—	97 Participants	102 Participants	131 Participants	103 Participants	131 Participants
Number of Participants in Each Geo-referenced Segment 233149_MA_Mangochi, ID-23314902	—	—	—	—	1 Participants	—	—	—	—	—
Number of Participants in Each Geo-referenced Segment 233149_MA_Mangochi, ID-23314911	—	—	—	—	143 Participants	239 Participants	240 Participants	279 Participants	254 Participants	187 Participants
Number of Participants in Each Geo-referenced Segment 233149_MA_Mangochi, ID-23314912	—	—	—	—	223 Participants	261 Participants	246 Participants	196 Participants	169 Participants	319 Participants
Number of Participants in Each Geo-referenced Segment 233149_MA_Mangochi, ID-23314921	—	—	—	—	16 Participants	—	—	—	—	2 Participants
Number of Participants in Each Geo-referenced Segment 233149_MA_Mangochi, ID-23314922	—	—	—	—	—	—	—	—	—	1 Participants
Number of Participants in Each Geo-referenced Segment 233149_MA_Monkey Bay, ID-23314911	—	—	—	—	2 Participants	18 Participants	—	—	—	—
Number of Participants in Each Geo-referenced Segment 233149_MA_Monkey Bay, ID-23314921	—	—	—	—	149 Participants	167 Participants	157 Participants	179 Participants	239 Participants	241 Participants
Number of Participants in Each Geo-referenced Segment 233150_MA_Chikwawa, ID-23315012	—	—	—	—	40 Participants	—	86 Participants	17 Participants	—	—
Number of Participants in Each Geo-referenced Segment 233150_MA_Chikwawa, ID-23315001	—	—	—	—	—	—	—	1 Participants	—	2 Participants
Number of Participants in Each Geo-referenced Segment 233150_MA_Chikwawa, ID-23315005	—	—	—	—	—	—	—	1 Participants	—	—
Number of Participants in Each Geo-referenced Segment 233150_MA_Chikwawa, ID-23315003	—	—	—	—	—	—	—	—	5 Participants	—
Number of Participants in Each Geo-referenced Segment 233150_MA_St Monfort, ID-23315001	—	—	—	—	1 Participants	—	—	—	—	1 Participants
Number of Participants in Each Geo-referenced Segment 233150_MA_St Monfort, ID-23315002	—	—	—	—	13 Participants	—	231 Participants	186 Participants	89 Participants	81 Participants
Number of Participants in Each Geo-referenced Segment 233150_MA_St Monfort, ID-23315003	—	—	—	—	14 Participants	—	174 Participants	264 Participants	233 Participants	251 Participants
Number of Participants in Each Geo-referenced Segment 233150_MA_St Monfort, ID-23315005	—	—	—	—	10 Participants	—	207 Participants	150 Participants	278 Participants	267 Participants
Number of Participants in Each Geo-referenced Segment 233150_MA_St Monfort, ID-23315011	—	—	—	—	—	—	—	—	—	1 Participants
Number of Participants in Each Geo-referenced Segment 235578_KE_Bondo, ID-23557801	—	—	—	—	108 Participants	80 Participants	49 Participants	64 Participants	69 Participants	67 Participants
Number of Participants in Each Geo-referenced Segment 235578_KE_Bondo, ID-23557804	—	—	—	—	115 Participants	63 Participants	119 Participants	122 Participants	119 Participants	114 Participants
Number of Participants in Each Geo-referenced Segment 235578_KE_Gem, ID-23557802	—	—	—	—	83 Participants	52 Participants	90 Participants	112 Participants	112 Participants	100 Participants
Number of Participants in Each Geo-referenced Segment 235578_KE_Gem, ID-23557804	—	—	—	—	124 Participants	93 Participants	99 Participants	114 Participants	129 Participants	123 Participants
Number of Participants in Each Geo-referenced Segment 235578_KE_Gem, ID-23557806	—	—	—	—	77 Participants	38 Participants	66 Participants	71 Participants	77 Participants	62 Participants
Number of Participants in Each Geo-referenced Segment 235579_KE_Nyando, ID-23557911	—	—	—	—	—	60 Participants	55 Participants	59 Participants	80 Participants	146 Participants
Number of Participants in Each Geo-referenced Segment 235579_KE_Nyando, ID-23557912	—	—	—	—	—	48 Participants	69 Participants	54 Participants	48 Participants	104 Participants
Number of Participants in Each Geo-referenced Segment 235579_KE_Nyando, ID-23557913	—	—	—	—	—	42 Participants	55 Participants	54 Participants	46 Participants	81 Participants
Number of Participants in Each Geo-referenced Segment 235579_KE_Nyando, ID-23557915	—	—	—	—	—	28 Participants	37 Participants	31 Participants	42 Participants	75 Participants
Number of Participants in Each Geo-referenced Segment 235579_KE_Nyando, ID-23557916	—	—	—	—	—	86 Participants	61 Participants	62 Participants	74 Participants	55 Participants
Number of Participants in Each Geo-referenced Segment 235579_KE_Nyando, ID-23557921	—	—	—	—	—	7 Participants	16 Participants	23 Participants	9 Participants	10 Participants
Number of Participants in Each Geo-referenced Segment 235579_KE_Nyando, ID-23557922	—	—	—	—	—	64 Participants	53 Participants	27 Participants	33 Participants	10 Participants
Number of Participants in Each Geo-referenced Segment 235579_KE_Nyando, ID-23557923	—	—	—	—	—	54 Participants	39 Participants	47 Participants	37 Participants	6 Participants
Number of Participants in Each Geo-referenced Segment 235579_KE_Nyando, ID-23557924	—	—	—	—	—	17 Participants	11 Participants	19 Participants	37 Participants	19 Participants
Number of Participants in Each Geo-referenced Segment 235579_KE_Nyando, ID-23557925	—	—	—	—	—	20 Participants	26 Participants	35 Participants	28 Participants	2 Participants
Number of Participants in Each Geo-referenced Segment 235579_KE_Nyando, ID-23557926	—	—	—	—	—	46 Participants	46 Participants	32 Participants	41 Participants	4 Participants
Number of Participants in Each Geo-referenced Segment 235579_KE_Nyando, ID-23557927	—	—	—	—	—	46 Participants	85 Participants	68 Participants	51 Participants	13 Participants

SECONDARY outcome

Timeframe: At Day 1 (survey completion visit)

Participants were categorized by the number of people living in the same house relative to enrolled participants as follows: less than of equal to (\<=) 3 per 1 enrolled (LE 3/1), 4-5 per 1 (4-5/1), more than (\>) 5 per 1 (GT 5/1); \<=3 per 2 enrolled (LE 3/2), 4-5 per 2 (4-5/2), \>5 per 2 (GT 5/2); \<=3 per 3 enrolled (LE 3/3), 4-5 per 3 (4-5/3), \>5 per 3 (GT 5/3); 4-5 per more than 3 enrolled (4-5/GT 3), \>5 per more than 3 enrolled (GT 5/GT 3). Participants were also categorized by parasite density: low (\<2500 parasites/μL), medium (2500-9999/μL), high (10000-19999/μL), very high (\>=20000/μL), negative, and missing.

Outcome measures

Outcome measures
Measure	Survey 1 Group n=4208 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 1.	Survey 2 Group n=4199 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 2.	Survey 3 Group n=2399 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 3.	Survey 4 Group n=3000 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 4.	Survey 5 Group n=5377 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 5.	Survey 6 Group n=5987 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 6.	Survey 7 Group n=7241 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 7.	Survey 8 Group n=7217 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 8.	Survey 9 Group n=7203 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 9.	Survey 10 Group n=7202 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 10.
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) 4-5/1, Low parasite density	246 Participants	260 Participants	243 Participants	199 Participants	160 Participants	185 Participants	221 Participants	161 Participants	146 Participants	109 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) 4-5/2, Medium parasite density	5 Participants	14 Participants	4 Participants	2 Participants	2 Participants	7 Participants	2 Participants	1 Participants	3 Participants	3 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) LE 3/1, Medium parasite density	87 Participants	64 Participants	35 Participants	39 Participants	47 Participants	37 Participants	34 Participants	37 Participants	25 Participants	40 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) LE 3/1, Very High parasite density	41 Participants	43 Participants	16 Participants	35 Participants	17 Participants	21 Participants	29 Participants	21 Participants	20 Participants	19 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) 4-5/1, Medium parasite density	122 Participants	120 Participants	86 Participants	77 Participants	72 Participants	87 Participants	77 Participants	57 Participants	58 Participants	54 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) 4-5/1, Very High parasite density	52 Participants	67 Participants	48 Participants	51 Participants	58 Participants	72 Participants	59 Participants	53 Participants	57 Participants	41 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) 4-5/1, Negative parasite density	864 Participants	856 Participants	604 Participants	819 Participants	1439 Participants	1609 Participants	2143 Participants	2188 Participants	2299 Participants	2162 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) 4-5/1, Missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) GT 5/1, Negative parasite density	1262 Participants	1464 Participants	462 Participants	756 Participants	1488 Participants	1689 Participants	2127 Participants	2222 Participants	2099 Participants	2538 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) LE 3/2, Low parasite density	7 Participants	4 Participants	2 Participants	5 Participants	16 Participants	2 Participants	2 Participants	1 Participants	1 Participants	1 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) LE 3/2, Negative parasite density	6 Participants	4 Participants	6 Participants	9 Participants	86 Participants	24 Participants	29 Participants	36 Participants	10 Participants	19 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) 4-5/2, High parasite density	5 Participants	3 Participants	0 Participants	1 Participants	4 Participants	2 Participants	0 Participants	3 Participants	1 Participants	2 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) GT 5/2, Low parasite density	8 Participants	21 Participants	20 Participants	7 Participants	12 Participants	28 Participants	25 Participants	8 Participants	15 Participants	23 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) GT 5/2, Medium parasite density	5 Participants	5 Participants	9 Participants	1 Participants	3 Participants	13 Participants	11 Participants	5 Participants	7 Participants	8 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) LE 3/3, Low parasite density	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) GT 5/2, High parasite density	4 Participants	7 Participants	3 Participants	1 Participants	4 Participants	4 Participants	0 Participants	4 Participants	2 Participants	4 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) GT 5/2, Very High parasite density	4 Participants	1 Participants	4 Participants	0 Participants	3 Participants	9 Participants	7 Participants	3 Participants	4 Participants	4 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) GT 5/2, Negative parasite density	233 Participants	236 Participants	26 Participants	21 Participants	86 Participants	138 Participants	137 Participants	186 Participants	170 Participants	193 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) 4-5/3, High parasite density	0 Participants	0 Participants	1 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) LE 3/3, Medium parasite density	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) LE 3/3, High parasite density	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) LE 3/3, Very High parasite density	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) LE 3/3, Negative parasite density	3 Participants	0 Participants	0 Participants	0 Participants	18 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) LE 3/3, Missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) 4-5/3, Low parasite density	0 Participants	1 Participants	2 Participants	0 Participants	2 Participants	0 Participants	0 Participants	1 Participants	2 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) 4-5/3, Medium parasite density	0 Participants	2 Participants	1 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) 4-5/3, Very High parasite density	0 Participants	1 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) 4-5/3, Negative parasite density	3 Participants	2 Participants	2 Participants	0 Participants	10 Participants	3 Participants	3 Participants	5 Participants	1 Participants	7 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) 4-5/3, Missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) GT 5/3, Low parasite density	0 Participants	3 Participants	7 Participants	1 Participants	0 Participants	2 Participants	2 Participants	1 Participants	1 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) GT 5/3, Medium parasite density	0 Participants	2 Participants	0 Participants	0 Participants	0 Participants	3 Participants	0 Participants	1 Participants	0 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) GT 5/3, High parasite density	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) GT 5/3, Very High parasite density	1 Participants	0 Participants	0 Participants	0 Participants	0 Participants	1 Participants	1 Participants	1 Participants	0 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) 4-5/GT 3, Medium parasite density	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) GT 5/3, Negative parasite density	29 Participants	28 Participants	8 Participants	2 Participants	3 Participants	9 Participants	12 Participants	6 Participants	5 Participants	9 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) GT 5/3, Missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) 4-5/GT 3, Low parasite density	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) 4-5/GT 3, High parasite density	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) 4-5/GT 3, Very High parasite density	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	1 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) 4-5/GT 3, Negative parasite density	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	3 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) 4-5/GT 3, Missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) GT 5/GT 3, Low parasite density	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) GT 5/GT 3, Medium parasite density	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) GT 5/GT 3, High parasite density	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) GT 5/GT 3, Very High parasite density	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) LE 3/2, Medium parasite density	2 Participants	0 Participants	1 Participants	1 Participants	8 Participants	0 Participants	0 Participants	1 Participants	1 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) LE 3/2, High parasite density	0 Participants	0 Participants	0 Participants	0 Participants	2 Participants	0 Participants	1 Participants	0 Participants	0 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) LE 3/2, Very High parasite density	3 Participants	0 Participants	1 Participants	1 Participants	0 Participants	1 Participants	0 Participants	2 Participants	0 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) LE 3/1, Low parasite density	180 Participants	161 Participants	124 Participants	109 Participants	84 Participants	93 Participants	81 Participants	76 Participants	98 Participants	56 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) LE 3/1, High parasite density	41 Participants	21 Participants	10 Participants	17 Participants	17 Participants	9 Participants	23 Participants	16 Participants	12 Participants	7 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) LE 3/2, Missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) 4-5/2, Low parasite density	8 Participants	14 Participants	20 Participants	8 Participants	12 Participants	10 Participants	12 Participants	16 Participants	8 Participants	10 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) 4-5/2, Very High parasite density	4 Participants	3 Participants	1 Participants	0 Participants	6 Participants	1 Participants	0 Participants	1 Participants	5 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) LE 3/1, Negative parasite density	561 Participants	337 Participants	284 Participants	410 Participants	1110 Participants	1209 Participants	1546 Participants	1525 Participants	1577 Participants	1353 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) LE 3/1, Missing	—	—	—	—	1 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) 4-5/1, High parasite density	49 Participants	42 Participants	29 Participants	36 Participants	52 Participants	38 Participants	40 Participants	28 Participants	28 Participants	20 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) 4-5/2, Negative parasite density	52 Participants	40 Participants	23 Participants	25 Participants	115 Participants	60 Participants	106 Participants	140 Participants	151 Participants	111 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) 4-5/2, Missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) GT 5/2, Missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) GT 5/1, Low parasite density	171 Participants	209 Participants	184 Participants	192 Participants	214 Participants	329 Participants	287 Participants	226 Participants	187 Participants	223 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) GT 5/1, Medium parasite density	65 Participants	73 Participants	65 Participants	89 Participants	101 Participants	138 Participants	91 Participants	70 Participants	97 Participants	88 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) GT 5/1, High parasite density	27 Participants	38 Participants	28 Participants	27 Participants	41 Participants	62 Participants	50 Participants	38 Participants	32 Participants	39 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) GT 5/1, Very High parasite density	50 Participants	53 Participants	40 Participants	59 Participants	94 Participants	92 Participants	83 Participants	77 Participants	77 Participants	59 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) GT 5/1, Missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) GT 5/GT 3, Negative parasite density	8 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by the Number of Participants Living in the Same House (by Parasite Density) GT 5/GT 3, Missing	—	—	—	—	0 Participants	—	—	—	—	—

SECONDARY outcome

Timeframe: At Day 1 (survey completion visit)

Participants were categorized by location as follows: situation area (rural, urban, semi-rural) and type of location (large city, small city, town, countryside). Participants were also categorized by parasite density: low (\<2500 parasites/μL), medium (2500-9999/μL), high (10000-19999/μL), very high (\>=20000/μL), negative, and missing.

Outcome measures

Outcome measures
Measure	Survey 1 Group n=4208 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 1.	Survey 2 Group n=4199 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 2.	Survey 3 Group n=2399 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 3.	Survey 4 Group n=3000 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 4.	Survey 5 Group n=5377 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 5.	Survey 6 Group n=5987 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 6.	Survey 7 Group n=7241 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 7.	Survey 8 Group n=7217 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 8.	Survey 9 Group n=7203 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 9.	Survey 10 Group n=7202 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 10.
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Type of location, Countryside, Medium parasite density	226 Participants	220 Participants	143 Participants	139 Participants	187 Participants	210 Participants	178 Participants	145 Participants	156 Participants	158 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Type of location, Countryside, High parasite density	95 Participants	84 Participants	52 Participants	51 Participants	87 Participants	91 Participants	100 Participants	75 Participants	63 Participants	58 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Situation area, Rural, Negative parasite density	2735 Participants	2752 Participants	1231 Participants	1806 Participants	4050 Participants	3857 Participants	5498 Participants	6009 Participants	5867 Participants	5564 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Situation area, Urban, Low parasite density	158 Participants	6 Participants	3 Participants	2 Participants	6 Participants	3 Participants	9 Participants	3 Participants	6 Participants	7 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Situation area, Urban, Medium parasite density	74 Participants	0 Participants	0 Participants	1 Participants	3 Participants	1 Participants	3 Participants	1 Participants	1 Participants	7 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Situation area, Semi-rural, Medium parasite density	2 Participants	28 Participants	6 Participants	5 Participants	4 Participants	34 Participants	10 Participants	2 Participants	7 Participants	8 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Situation area, Semi-rural, High parasite density	2 Participants	16 Participants	3 Participants	6 Participants	5 Participants	11 Participants	2 Participants	1 Participants	1 Participants	5 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Situation area, Semi-rural, Negative parasite density	74 Participants	163 Participants	149 Participants	166 Participants	188 Participants	800 Participants	312 Participants	124 Participants	223 Participants	579 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Type of location, Large city, Low parasite density	0 Participants	0 Participants	0 Participants	1 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	1 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Type of location, Small city, Low parasite density	1 Participants	1 Participants	0 Participants	0 Participants	0 Participants	0 Participants	1 Participants	0 Participants	2 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Type of location, Small city, Medium parasite density	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	1 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Type of location, Small city, Very High parasite density	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Type of location, Town, Very High parasite density	43 Participants	54 Participants	50 Participants	55 Participants	45 Participants	61 Participants	51 Participants	30 Participants	36 Participants	29 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Type of location, Countryside, Low parasite density	455 Participants	510 Participants	405 Participants	349 Participants	403 Participants	495 Participants	524 Participants	428 Participants	385 Participants	319 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Type of location, Countryside, Very High parasite density	111 Participants	114 Participants	60 Participants	91 Participants	133 Participants	136 Participants	128 Participants	128 Participants	128 Participants	94 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Type of location, Countryside, Negative parasite density	2493 Participants	2477 Participants	869 Participants	1169 Participants	3774 Participants	3660 Participants	5044 Participants	5568 Participants	5454 Participants	5147 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Type of location, Town, Negative parasite density	515 Participants	475 Participants	546 Participants	869 Participants	574 Participants	1067 Participants	1028 Participants	739 Participants	797 Participants	1240 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Situation area, Rural, Low parasite density	449 Participants	559 Participants	512 Participants	484 Participants	485 Participants	559 Participants	582 Participants	483 Participants	434 Participants	380 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Type of location, Town, Missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Situation area, Rural, Medium parasite density	210 Participants	252 Participants	195 Participants	203 Participants	226 Participants	250 Participants	202 Participants	169 Participants	183 Participants	178 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Situation area, Rural, High parasite density	92 Participants	95 Participants	67 Participants	76 Participants	105 Participants	104 Participants	112 Participants	87 Participants	71 Participants	67 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Situation area, Rural, Very High parasite density	109 Participants	150 Participants	102 Participants	133 Participants	169 Participants	166 Participants	170 Participants	155 Participants	159 Participants	116 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Situation area, Rural, Missing	—	—	—	—	1 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Situation area, Urban, High parasite density	32 Participants	0 Participants	1 Participants	0 Participants	0 Participants	0 Participants	0 Participants	1 Participants	3 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Situation area, Urban, Very High parasite density	41 Participants	1 Participants	0 Participants	1 Participants	3 Participants	1 Participants	4 Participants	1 Participants	3 Participants	1 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Situation area, Urban, Negative parasite density	212 Participants	52 Participants	35 Participants	70 Participants	117 Participants	84 Participants	293 Participants	175 Participants	225 Participants	249 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Situation area, Urban, Missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Situation area, Semi-rural, Low parasite density	13 Participants	108 Participants	87 Participants	35 Participants	9 Participants	87 Participants	39 Participants	4 Participants	18 Participants	35 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Situation area, Semi-rural, Very High parasite density	5 Participants	17 Participants	8 Participants	12 Participants	6 Participants	30 Participants	5 Participants	2 Participants	2 Participants	6 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Situation area, Semi-rural, Missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Type of location, Large city, Medium parasite density	1 Participants	1 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Type of location, Large city, High parasite density	0 Participants	1 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Type of location, Large city, Very High parasite density	1 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Type of location, Large city, Negative parasite density	10 Participants	2 Participants	0 Participants	3 Participants	0 Participants	1 Participants	6 Participants	0 Participants	19 Participants	4 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Type of location, Large city, Missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Type of location, Small city, High parasite density	0 Participants	1 Participants	0 Participants	0 Participants	0 Participants	1 Participants	0 Participants	0 Participants	0 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Type of location, Small city, Negative parasite density	3 Participants	13 Participants	0 Participants	1 Participants	7 Participants	13 Participants	25 Participants	1 Participants	45 Participants	1 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Type of location, Small city, Missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Type of location, Town, Low parasite density	164 Participants	162 Participants	197 Participants	171 Participants	97 Participants	154 Participants	105 Participants	62 Participants	71 Participants	102 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Type of location, Town, Medium parasite density	59 Participants	59 Participants	58 Participants	70 Participants	46 Participants	75 Participants	37 Participants	27 Participants	34 Participants	35 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Type of location, Town, High parasite density	31 Participants	25 Participants	19 Participants	31 Participants	23 Participants	23 Participants	14 Participants	14 Participants	12 Participants	14 Participants
Number of Participants Experiencing Malaria Risk Categorized by Location (by Parasite Density) Type of location, Countryside, Missing	—	—	—	—	1 Participants	—	—	—	—	—

SECONDARY outcome

Timeframe: At Day 1 (survey completion visit)

Participants were categorized by house characteristics as follows: wall material (mud, brick, cement/plaster, clay, other), floor material (natural, rudimentary, vinyl/asphalt strips, parquet/polished wood, ceramic tiles, cement, carpet, clay, other), roof type (iron sheet, tiles, clay, other), window type (closed, open, no window, partially open, other), presence of nets (not present, present on all windows, present on some windows, other, missing), main drinking water source (closed, open), whether the open source was in the compound (yes, no, not available \[NA\]), and presence or absence of electricity. Participants were also categorized by parasite density: low (\<2500 parasites/μL), medium (2500-9999/μL), high (10000-19999/μL), very high (\>=20000/μL), negative, and missing.

Outcome measures

Outcome measures
Measure	Survey 1 Group n=4208 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 1.	Survey 2 Group n=4199 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 2.	Survey 3 Group n=2399 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 3.	Survey 4 Group n=3000 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 4.	Survey 5 Group n=5377 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 5.	Survey 6 Group n=5987 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 6.	Survey 7 Group n=7241 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 7.	Survey 8 Group n=7217 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 8.	Survey 9 Group n=7203 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 9.	Survey 10 Group n=7202 Participants Participants aged 6 months to \<10 years, enrolled in the current EPI-MAL-005 study from sites that participated in EPI-MAL-002/-003, during study Year 10.
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Mud, High parasite density	97 Participants	81 Participants	38 Participants	48 Participants	59 Participants	75 Participants	55 Participants	44 Participants	38 Participants	32 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Mud, Negative parasite density	1377 Participants	1375 Participants	643 Participants	1044 Participants	1462 Participants	2076 Participants	2306 Participants	2524 Participants	2009 Participants	1925 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Brick, Negative parasite density	881 Participants	804 Participants	417 Participants	535 Participants	1841 Participants	1065 Participants	1938 Participants	1764 Participants	2055 Participants	2609 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Cement/Plaster, Negative parasite density	373 Participants	402 Participants	186 Participants	313 Participants	623 Participants	872 Participants	1306 Participants	1541 Participants	1163 Participants	1175 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Cement/Paint, very high parasite density	6 Participants	1 Participants	4 Participants	3 Participants	16 Participants	18 Participants	8 Participants	6 Participants	13 Participants	5 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Clay, medium parasite density	2 Participants	4 Participants	18 Participants	1 Participants	18 Participants	7 Participants	2 Participants	1 Participants	4 Participants	6 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Clay, high parasite density	0 Participants	2 Participants	6 Participants	1 Participants	7 Participants	2 Participants	6 Participants	1 Participants	0 Participants	4 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Clay, negative parasite density	6 Participants	40 Participants	96 Participants	10 Participants	167 Participants	70 Participants	104 Participants	84 Participants	127 Participants	111 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Other, high parasite density	5 Participants	0 Participants	0 Participants	0 Participants	0 Participants	2 Participants	1 Participants	0 Participants	0 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Other, very high parasite density	4 Participants	0 Participants	0 Participants	0 Participants	1 Participants	0 Participants	3 Participants	3 Participants	0 Participants	2 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Natural floor, medium parasite density	133 Participants	140 Participants	85 Participants	76 Participants	124 Participants	131 Participants	88 Participants	69 Participants	85 Participants	85 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Natural floor, very high parasite density	61 Participants	84 Participants	37 Participants	57 Participants	84 Participants	83 Participants	69 Participants	74 Participants	66 Participants	45 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Rudimentary floor, low parasite density	0 Participants	—	3 Participants	—	—	—	0 Participants	1 Participants	—	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Rudimentary floor, negative parasite density	1 Participants	—	13 Participants	—	—	—	1 Participants	122 Participants	—	1 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Ceramic tiles, low parasite density	1 Participants	0 Participants	6 Participants	1 Participants	3 Participants	7 Participants	5 Participants	4 Participants	10 Participants	5 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Ceramic tiles, medium parasite density	1 Participants	0 Participants	0 Participants	3 Participants	0 Participants	6 Participants	1 Participants	2 Participants	5 Participants	4 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Ceramic tiles, high parasite density	1 Participants	0 Participants	0 Participants	0 Participants	0 Participants	2 Participants	1 Participants	0 Participants	0 Participants	1 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Ceramic tiles, very high parasite density	0 Participants	1 Participants	2 Participants	1 Participants	1 Participants	3 Participants	3 Participants	6 Participants	9 Participants	2 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Cement, low parasite density	336 Participants	—	327 Participants	305 Participants	209 Participants	290 Participants	304 Participants	264 Participants	172 Participants	193 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Cement, medium parasite density	136 Participants	—	101 Participants	124 Participants	80 Participants	114 Participants	98 Participants	80 Participants	70 Participants	77 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Cement, very high parasite density	84 Participants	—	51 Participants	87 Participants	78 Participants	83 Participants	74 Participants	62 Participants	67 Participants	56 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Clay, very high parasite density	9 Participants	4 Participants	17 Participants	11 Participants	15 Participants	15 Participants	29 Participants	15 Participants	14 Participants	18 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Clay, negative parasite density	14 Participants	6 Participants	108 Participants	13 Participants	886 Participants	362 Participants	1088 Participants	1124 Participants	847 Participants	1103 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Roof: Grass/Palm, negative parasite density	784 Participants	703 Participants	197 Participants	140 Participants	1187 Participants	807 Participants	1278 Participants	1301 Participants	1165 Participants	1198 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Roof: Tiles, high parasite density	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	—	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Roof: Tiles, very high parasite density	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	—	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Roof: Clay, low parasite density	97 Participants	120 Participants	86 Participants	42 Participants	13 Participants	2 Participants	0 Participants	5 Participants	7 Participants	5 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Roof: Clay, medium parasite density	55 Participants	36 Participants	17 Participants	9 Participants	3 Participants	2 Participants	0 Participants	5 Participants	3 Participants	2 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Roof: Other, high parasite density	0 Participants	0 Participants	—	2 Participants	0 Participants	6 Participants	5 Participants	4 Participants	0 Participants	2 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Roof: Other, very high parasite density	1 Participants	0 Participants	—	12 Participants	0 Participants	9 Participants	3 Participants	4 Participants	8 Participants	2 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Windows/eaves: Closed, low parasite density	236 Participants	236 Participants	286 Participants	253 Participants	115 Participants	179 Participants	131 Participants	123 Participants	123 Participants	130 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Windows/eaves: Closed, medium parasite density	115 Participants	103 Participants	79 Participants	104 Participants	46 Participants	66 Participants	51 Participants	46 Participants	53 Participants	59 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Windows/eaves: Closed, high parasite density	44 Participants	45 Participants	32 Participants	34 Participants	24 Participants	32 Participants	33 Participants	11 Participants	25 Participants	17 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Windows/eaves: Closed, negative parasite density	677 Participants	487 Participants	587 Participants	911 Participants	1023 Participants	1368 Participants	1251 Participants	1494 Participants	1964 Participants	2109 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Windows/eaves: Closed, missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Windows/eaves: No Windows, low parasite density	139 Participants	111 Participants	40 Participants	60 Participants	112 Participants	149 Participants	122 Participants	87 Participants	109 Participants	89 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Windows/eaves: No Windows, medium parasite density	67 Participants	45 Participants	25 Participants	23 Participants	75 Participants	86 Participants	61 Participants	40 Participants	50 Participants	58 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Windows/eaves: Open, medium parasite density	83 Participants	84 Participants	52 Participants	58 Participants	87 Participants	73 Participants	37 Participants	66 Participants	62 Participants	30 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Windows/eaves: Partially open, low parasite density	35 Participants	111 Participants	106 Participants	57 Participants	76 Participants	139 Participants	204 Participants	83 Participants	76 Participants	96 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Windows/eaves: Partially open, high parasite density	9 Participants	17 Participants	22 Participants	8 Participants	11 Participants	28 Participants	22 Participants	16 Participants	15 Participants	17 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Windows/eaves: Partially open, missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Windows/eaves: Other, low parasite density	1 Participants	0 Participants	—	—	0 Participants	0 Participants	—	—	—	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Windows/eaves: Other, high parasite density	0 Participants	0 Participants	—	—	0 Participants	0 Participants	—	—	—	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Nets: Nets not present, high parasite density	101 Participants	85 Participants	56 Participants	59 Participants	55 Participants	59 Participants	62 Participants	46 Participants	40 Participants	32 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Nets: Nets present on all windows, medium parasite density	19 Participants	18 Participants	23 Participants	22 Participants	40 Participants	44 Participants	32 Participants	28 Participants	33 Participants	25 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Nets: Nets present on all windows, high parasite density	5 Participants	7 Participants	7 Participants	12 Participants	17 Participants	20 Participants	17 Participants	17 Participants	14 Participants	9 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Nets: Nets present on all windows, very high parasite density	16 Participants	17 Participants	16 Participants	15 Participants	29 Participants	50 Participants	26 Participants	18 Participants	23 Participants	22 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Nets: Nets present on all windows, missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Nets: Nets present on some windows, negative parasite density	99 Participants	88 Participants	11 Participants	57 Participants	130 Participants	135 Participants	103 Participants	124 Participants	118 Participants	216 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Nets: Other, low parasite density	71 Participants	112 Participants	40 Participants	60 Participants	94 Participants	149 Participants	124 Participants	88 Participants	110 Participants	91 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Nets: Other, medium parasite density	30 Participants	46 Participants	25 Participants	23 Participants	66 Participants	86 Participants	61 Participants	1 Participants	50 Participants	63 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Nets: Other, high parasite density	18 Participants	17 Participants	7 Participants	9 Participants	23 Participants	36 Participants	34 Participants	2 Participants	20 Participants	26 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Nets: Other, very high parasite density	17 Participants	36 Participants	16 Participants	13 Participants	47 Participants	47 Participants	53 Participants	0 Participants	44 Participants	30 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Nets: Other, negative parasite density	287 Participants	918 Participants	124 Participants	144 Participants	557 Participants	913 Participants	1074 Participants	124 Participants	973 Participants	1024 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Nets: Other, missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Nets: Missing, low parasite density	—	—	—	—	24 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main source of the drinking water: Closed water source, negative parasite density	2070 Participants	1948 Participants	1002 Participants	1491 Participants	3455 Participants	3546 Participants	4730 Participants	4958 Participants	4984 Participants	4973 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main source of the drinking water: Closed water source, missing	—	—	—	—	1 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main source of the drinking water: Open water source, low parasite density	232 Participants	316 Participants	225 Participants	187 Participants	134 Participants	211 Participants	169 Participants	150 Participants	136 Participants	142 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) The open source is in compound: Yes, negative parasite density	253 Participants	250 Participants	72 Participants	93 Participants	133 Participants	175 Participants	212 Participants	149 Participants	251 Participants	272 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) The open source is in compound: No, low parasite density	168 Participants	218 Participants	168 Participants	170 Participants	107 Participants	177 Participants	140 Participants	141 Participants	110 Participants	110 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) The open source is in compound: NA, medium parasite density	172 Participants	145 Participants	116 Participants	139 Participants	144 Participants	160 Participants	127 Participants	112 Participants	129 Participants	128 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) The open source is in compound: NA, negative parasite density	2070 Participants	1948 Participants	1002 Participants	1491 Participants	3455 Participants	3546 Participants	4730 Participants	4958 Participants	4984 Participants	4973 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) The open source is in compound: NA, missing	—	—	—	—	1 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Number of participants in houses with no presence of electricity, low parasite density	522 Participants	463 Participants	372 Participants	289 Participants	337 Participants	465 Participants	450 Participants	356 Participants	332 Participants	314 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Number of participants in houses with no presence of electricity, high parasite density	118 Participants	72 Participants	60 Participants	47 Participants	72 Participants	89 Participants	94 Participants	70 Participants	60 Participants	57 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Number of participants in houses with no presence of electricity, very high parasite density	125 Participants	128 Participants	84 Participants	98 Participants	103 Participants	141 Participants	138 Participants	130 Participants	123 Participants	88 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Number of participants in houses with no presence of electricity, negative parasite density	2384 Participants	2336 Participants	969 Participants	1096 Participants	2975 Participants	3167 Participants	4381 Participants	4340 Participants	4203 Participants	4217 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Clay, low parasite density	32 Participants	30 Participants	42 Participants	5 Participants	69 Participants	43 Participants	89 Participants	43 Participants	52 Participants	41 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Clay, medium parasite density	15 Participants	11 Participants	15 Participants	3 Participants	29 Participants	18 Participants	27 Participants	20 Participants	16 Participants	26 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Brick, low parasite density	114 Participants	105 Participants	297 Participants	187 Participants	173 Participants	113 Participants	164 Participants	97 Participants	91 Participants	133 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Brick, Medium parasite density	37 Participants	41 Participants	83 Participants	62 Participants	53 Participants	30 Participants	45 Participants	33 Participants	34 Participants	60 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Brick, High parasite density	17 Participants	20 Participants	21 Participants	21 Participants	28 Participants	8 Participants	21 Participants	17 Participants	12 Participants	20 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Brick, very high parasite density	21 Participants	31 Participants	36 Participants	46 Participants	32 Participants	23 Participants	40 Participants	21 Participants	23 Participants	31 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Brick, missing	—	—	—	—	1 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Cement/Plaster, low parasite density	57 Participants	46 Participants	37 Participants	54 Participants	66 Participants	134 Participants	136 Participants	135 Participants	84 Participants	86 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Cement/Plaster, Medium parasite density	25 Participants	16 Participants	14 Participants	31 Participants	22 Participants	66 Participants	51 Participants	50 Participants	35 Participants	29 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Cement/Plaster, High parasite density	7 Participants	6 Participants	5 Participants	10 Participants	10 Participants	22 Participants	27 Participants	27 Participants	15 Participants	15 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Cement/Plaster, very high parasite density	25 Participants	21 Participants	17 Participants	15 Participants	26 Participants	37 Participants	37 Participants	38 Participants	43 Participants	31 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Cement/Plaster, missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Cement/Paint, low parasite density	14 Participants	12 Participants	14 Participants	23 Participants	21 Participants	70 Participants	21 Participants	13 Participants	61 Participants	20 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Cement/Paint, Medium parasite density	8 Participants	10 Participants	3 Participants	6 Participants	10 Participants	18 Participants	10 Participants	6 Participants	22 Participants	9 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Cement/Paint, High parasite density	0 Participants	2 Participants	1 Participants	2 Participants	6 Participants	6 Participants	4 Participants	0 Participants	10 Participants	1 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Cement/Paint, Negative parasite density	329 Participants	342 Participants	72 Participants	138 Participants	227 Participants	604 Participants	402 Participants	273 Participants	895 Participants	490 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Cement/Paint, missing	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Clay, Low parasite density	1 Participants	9 Participants	34 Participants	2 Participants	17 Participants	9 Participants	7 Participants	6 Participants	13 Participants	19 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Clay, very high parasite density	0 Participants	7 Participants	14 Participants	0 Participants	9 Participants	4 Participants	3 Participants	0 Participants	4 Participants	6 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Clay, missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Other, low parasite density	17 Participants	1 Participants	2 Participants	1 Participants	6 Participants	1 Participants	4 Participants	8 Participants	7 Participants	3 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Other, medium parasite density	10 Participants	0 Participants	0 Participants	0 Participants	1 Participants	2 Participants	1 Participants	2 Participants	2 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Other, negative parasite density	55 Participants	4 Participants	1 Participants	2 Participants	35 Participants	54 Participants	47 Participants	122 Participants	66 Participants	82 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material: Walls: Other, missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Natural floor, low parasite density	248 Participants	325 Participants	223 Participants	204 Participants	217 Participants	263 Participants	228 Participants	171 Participants	167 Participants	171 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Natural floor, high parasite density	63 Participants	49 Participants	27 Participants	32 Participants	54 Participants	55 Participants	46 Participants	24 Participants	28 Participants	28 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Natural floor, negative parasite density	1173 Participants	1384 Participants	506 Participants	652 Participants	1615 Participants	1730 Participants	1963 Participants	1844 Participants	2063 Participants	1851 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Natural floor, missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Rudimentary floor, medium parasite density	0 Participants	—	0 Participants	—	—	—	0 Participants	0 Participants	—	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Rudimentary floor, high parasite density	0 Participants	—	1 Participants	—	—	—	0 Participants	0 Participants	—	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Rudimentary floor, very high parasite density	0 Participants	—	3 Participants	—	—	—	0 Participants	3 Participants	—	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Vinyl or asphalt strips, low parasite density	—	—	—	—	—	—	—	—	—	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Vinyl or asphalt strips, medium parasite density	—	—	—	—	—	—	—	—	—	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Vinyl or asphalt strips, high parasite density	—	—	—	—	—	—	—	—	—	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Vinyl or asphalt strips, very high parasite density	—	—	—	—	—	—	—	—	—	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Vinyl or asphalt strips, negative parasite density	—	—	—	—	—	—	—	—	—	1 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Parquet/ polished wood, low parasite density	—	0 Participants	—	—	—	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Parquet/ polished wood, medium parasite density	—	0 Participants	—	—	—	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Parquet/ polished wood, high parasite density	—	0 Participants	—	—	—	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Parquet/ polished wood, very high parasite density	—	0 Participants	—	—	—	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Parquet/ polished wood, negative parasite density	—	1 Participants	—	—	—	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Ceramic tiles, negative parasite density	60 Participants	70 Participants	13 Participants	10 Participants	41 Participants	89 Participants	104 Participants	169 Participants	217 Participants	192 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Ceramic tiles, missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Cement, high parasite density	54 Participants	—	37 Participants	49 Participants	37 Participants	43 Participants	46 Participants	56 Participants	33 Participants	32 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Cement, negative parasite density	1686 Participants	—	773 Participants	1313 Participants	1790 Participants	2143 Participants	2855 Participants	3075 Participants	2527 Participants	2900 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Cement, missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Carpet, low parasite density	3 Participants	0 Participants	1 Participants	6 Participants	2 Participants	39 Participants	4 Participants	1 Participants	47 Participants	12 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Carpet, medium parasite density	1 Participants	0 Participants	0 Participants	2 Participants	0 Participants	13 Participants	0 Participants	1 Participants	14 Participants	1 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Carpet, high parasite density	1 Participants	0 Participants	0 Participants	0 Participants	1 Participants	4 Participants	1 Participants	0 Participants	6 Participants	2 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Carpet, very high parasite density	1 Participants	0 Participants	0 Participants	0 Participants	0 Participants	10 Participants	4 Participants	0 Participants	8 Participants	2 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Mud, low parasite density	417 Participants	500 Participants	218 Participants	257 Participants	217 Participants	322 Participants	298 Participants	231 Participants	202 Participants	161 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Mud, Medium parasite density	204 Participants	209 Participants	83 Participants	110 Participants	129 Participants	162 Participants	106 Participants	80 Participants	94 Participants	89 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Mud, Very High parasite density	99 Participants	108 Participants	39 Participants	82 Participants	94 Participants	115 Participants	88 Participants	90 Participants	81 Participants	48 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Carpet, negative parasite density	87 Participants	28 Participants	2 Participants	32 Participants	19 Participants	358 Participants	87 Participants	48 Participants	630 Participants	343 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Carpet, missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Walls: Mud, missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Other, medium parasite density	—	—	—	1 Participants	0 Participants	3 Participants	1 Participants	0 Participants	1 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Other, high parasite density	—	—	—	0 Participants	1 Participants	3 Participants	0 Participants	3 Participants	0 Participants	1 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Other, very high parasite density	—	—	—	0 Participants	0 Participants	3 Participants	0 Participants	1 Participants	0 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Clay, high parasite density	7 Participants	3 Participants	6 Participants	1 Participants	17 Participants	8 Participants	20 Participants	6 Participants	8 Participants	8 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Other, negative parasite density	—	—	—	21 Participants	3 Participants	59 Participants	5 Participants	46 Participants	31 Participants	1 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Other, missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Roof: Grass/Palm, low parasite density	128 Participants	89 Participants	71 Participants	50 Participants	115 Participants	90 Participants	116 Participants	67 Participants	74 Participants	57 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Roof: Grass/Palm, medium parasite density	58 Participants	42 Participants	23 Participants	21 Participants	52 Participants	32 Participants	31 Participants	26 Participants	20 Participants	35 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Roof: Grass/Palm, high parasite density	29 Participants	12 Participants	13 Participants	5 Participants	22 Participants	10 Participants	19 Participants	16 Participants	10 Participants	10 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Clay, missing	—	—	—	—	1 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Floor: Other, low parasite density	—	—	—	0 Participants	0 Participants	7 Participants	0 Participants	6 Participants	10 Participants	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Windows/eaves: Partially open, very high parasite density	15 Participants	31 Participants	30 Participants	20 Participants	18 Participants	52 Participants	49 Participants	12 Participants	37 Participants	40 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Windows/eaves: Partially open, negative parasite density	206 Participants	571 Participants	351 Participants	326 Participants	769 Participants	1108 Participants	1828 Participants	1104 Participants	1308 Participants	1518 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Windows/eaves: Other, medium parasite density	0 Participants	0 Participants	—	—	0 Participants	0 Participants	—	—	—	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Windows/eaves: Other, very high parasite density	0 Participants	0 Participants	—	—	0 Participants	0 Participants	—	—	—	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Windows/eaves: Other, negative parasite density	7 Participants	38 Participants	—	—	1 Participants	2 Participants	—	—	—	2 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Windows/eaves: Other, missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Roof: Grass/Palm, missing	—	—	—	—	1 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Nets: Nets not present, low parasite density	505 Participants	506 Participants	499 Participants	393 Participants	269 Participants	340 Participants	366 Participants	290 Participants	244 Participants	230 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Nets: Nets not present, medium parasite density	231 Participants	216 Participants	152 Participants	160 Participants	114 Participants	148 Participants	118 Participants	103 Participants	107 Participants	103 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Nets: Nets not present, very high parasite density	117 Participants	114 Participants	77 Participants	117 Participants	83 Participants	91 Participants	99 Participants	89 Participants	97 Participants	66 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Nets: Nets not present, negative parasite density	2313 Participants	1550 Participants	1100 Participants	1407 Participants	2765 Participants	2486 Participants	3636 Participants	3724 Participants	3728 Participants	3730 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Nets: Nets not present, missing	—	—	—	—	1 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Nets: Nets present on all windows, low parasite density	32 Participants	48 Participants	58 Participants	60 Participants	101 Participants	147 Participants	129 Participants	104 Participants	100 Participants	84 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Roof: Grass/Palm, very high parasite density	20 Participants	22 Participants	14 Participants	10 Participants	30 Participants	25 Participants	26 Participants	18 Participants	18 Participants	20 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Roof: Iron sheet, low parasite density	386 Participants	462 Participants	445 Participants	418 Participants	371 Participants	540 Participants	486 Participants	407 Participants	365 Participants	353 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Roof: Iron sheet, medium parasite density	170 Participants	201 Participants	159 Participants	172 Participants	178 Participants	236 Participants	175 Participants	138 Participants	161 Participants	154 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Roof: Iron sheet, high parasite density	72 Participants	84 Participants	57 Participants	70 Participants	86 Participants	99 Participants	88 Participants	68 Participants	63 Participants	55 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Roof: Iron sheet, very high parasite density	107 Participants	129 Participants	90 Participants	115 Participants	147 Participants	163 Participants	149 Participants	135 Participants	136 Participants	100 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Roof: Iron sheet, negative parasite density	2111 Participants	2205 Participants	1144 Participants	1729 Participants	3056 Participants	3728 Participants	4636 Participants	4824 Participants	5026 Participants	5081 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Roof: Iron sheet, missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Roof: Tiles, low parasite density	1 Participants	2 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	—	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Roof: Tiles, medium parasite density	0 Participants	0 Participants	2 Participants	0 Participants	0 Participants	0 Participants	0 Participants	0 Participants	—	0 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Roof: Tiles, negative parasite density	18 Participants	18 Participants	3 Participants	2 Participants	4 Participants	3 Participants	3 Participants	5 Participants	—	3 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Roof: Tiles, missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Windows/eaves: Closed, very high parasite density	44 Participants	48 Participants	35 Participants	69 Participants	38 Participants	56 Participants	30 Participants	32 Participants	33 Participants	28 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Roof: Clay, high parasite density	25 Participants	15 Participants	1 Participants	5 Participants	2 Participants	0 Participants	2 Participants	1 Participants	2 Participants	5 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Roof: Clay, very high parasite density	27 Participants	17 Participants	6 Participants	9 Participants	1 Participants	0 Participants	1 Participants	1 Participants	2 Participants	1 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Roof: Clay, negative parasite density	61 Participants	39 Participants	71 Participants	80 Participants	100 Participants	17 Participants	8 Participants	47 Participants	47 Participants	65 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Roof: Clay, missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Roof: Other, low parasite density	8 Participants	0 Participants	—	11 Participants	1 Participants	17 Participants	28 Participants	11 Participants	12 Participants	7 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Roof: Other, medium parasite density	3 Participants	1 Participants	—	7 Participants	0 Participants	15 Participants	9 Participants	3 Participants	7 Participants	2 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Roof: Other, negative parasite density	47 Participants	2 Participants	—	91 Participants	8 Participants	186 Participants	178 Participants	131 Participants	77 Participants	45 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Roof: Other, missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Windows/eaves: No Windows, high parasite density	36 Participants	17 Participants	7 Participants	9 Participants	36 Participants	36 Participants	34 Participants	24 Participants	20 Participants	25 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Windows/eaves: No Windows, very high parasite density	29 Participants	35 Participants	15 Participants	13 Participants	64 Participants	47 Participants	53 Participants	51 Participants	43 Participants	28 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Windows/eaves: No Windows, negative parasite density	942 Participants	821 Participants	124 Participants	143 Participants	660 Participants	911 Participants	1063 Participants	987 Participants	956 Participants	944 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Windows/eaves: No Windows, missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Windows/eaves: Open, low parasite density	209 Participants	215 Participants	170 Participants	151 Participants	197 Participants	182 Participants	173 Participants	197 Participants	150 Participants	107 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Nets: Nets present on all windows, negative parasite density	322 Participants	411 Participants	180 Participants	434 Participants	773 Participants	1207 Participants	1290 Participants	1462 Participants	1496 Participants	1422 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Nets: Nets present on some windows, low parasite density	12 Participants	7 Participants	5 Participants	8 Participants	12 Participants	13 Participants	11 Participants	8 Participants	4 Participants	17 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Windows/eaves: Open, high parasite density	37 Participants	32 Participants	10 Participants	31 Participants	39 Participants	19 Participants	25 Participants	38 Participants	15 Participants	13 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Windows/eaves: Open, very high parasite density	67 Participants	54 Participants	30 Participants	44 Participants	58 Participants	42 Participants	47 Participants	63 Participants	51 Participants	27 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Nets: Nets present on some windows, very high parasite density	5 Participants	1 Participants	1 Participants	1 Participants	1 Participants	9 Participants	1 Participants	0 Participants	0 Participants	5 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Windows/eaves: Open, negative parasite density	1189 Participants	1050 Participants	353 Participants	662 Participants	1902 Participants	1352 Participants	1961 Participants	2723 Participants	2087 Participants	1819 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Windows/eaves: Open missing	—	—	—	—	1 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Windows/eaves: Partially open, medium parasite density	21 Participants	48 Participants	45 Participants	24 Participants	25 Participants	60 Participants	66 Participants	30 Participants	26 Participants	46 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) The open source is in compound: Yes, missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) The open source is in compound: No, medium parasite density	93 Participants	101 Participants	75 Participants	62 Participants	82 Participants	100 Participants	77 Participants	55 Participants	49 Participants	53 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) The open source is in compound: No, high parasite density	47 Participants	35 Participants	17 Participants	25 Participants	40 Participants	40 Participants	33 Participants	31 Participants	24 Participants	24 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) The open source is in compound: No, very high parasite density	44 Participants	63 Participants	31 Participants	46 Participants	66 Participants	55 Participants	53 Participants	68 Participants	52 Participants	37 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) The open source is in compound: No, negative parasite density	698 Participants	769 Participants	341 Participants	458 Participants	767 Participants	1020 Participants	1161 Participants	1201 Participants	1080 Participants	1147 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Nets: Nets present on some windows, medium parasite density	6 Participants	0 Participants	1 Participants	4 Participants	3 Participants	7 Participants	4 Participants	1 Participants	1 Participants	2 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Nets: Nets present on some windows, high parasite density	2 Participants	2 Participants	1 Participants	2 Participants	1 Participants	0 Participants	1 Participants	2 Participants	1 Participants	5 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Nets: Nets present on some windows, missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) The open source is in compound: No, missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) The open source is in compound: NA, low parasite density	388 Participants	357 Participants	377 Participants	334 Participants	366 Participants	438 Participants	461 Participants	340 Participants	322 Participants	280 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) The open source is in compound: NA, high parasite density	67 Participants	66 Participants	52 Participants	53 Participants	63 Participants	68 Participants	81 Participants	57 Participants	48 Participants	45 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) The open source is in compound: NA, very high parasite density	94 Participants	91 Participants	72 Participants	91 Participants	103 Participants	126 Participants	112 Participants	85 Participants	103 Participants	78 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Number of participants in houses with the presence of electricity, low parasite density	98 Participants	210 Participants	230 Participants	232 Participants	163 Participants	184 Participants	180 Participants	134 Participants	126 Participants	108 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Number of participants in houses with the presence of electricity, medium parasite density	45 Participants	80 Participants	51 Participants	88 Participants	83 Participants	38 Participants	40 Participants	36 Participants	49 Participants	39 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Number of participants in houses with the presence of electricity, high parasite density	8 Participants	39 Participants	11 Participants	35 Participants	38 Participants	26 Participants	20 Participants	19 Participants	15 Participants	15 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Number of participants in houses with the presence of electricity, very high parasite density	30 Participants	40 Participants	26 Participants	48 Participants	75 Participants	56 Participants	41 Participants	28 Participants	41 Participants	35 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Number of participants in houses with the presence of electricity, negative parasite density	637 Participants	631 Participants	446 Participants	946 Participants	1481 Participants	1574 Participants	1722 Participants	1968 Participants	2112 Participants	2175 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Number of participants in houses with the presence of electricity, missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Number of participants in houses with no presence of electricity, medium parasite density	241 Participants	200 Participants	150 Participants	121 Participants	150 Participants	247 Participants	175 Participants	136 Participants	142 Participants	154 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Number of participants in houses with no presence of electricity, missing	—	—	—	—	1 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Nets: Missing, medium parasite density	—	—	—	—	10 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Nets: Missing, high parasite density	—	—	—	—	14 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Nets: Missing, very high parasite density	—	—	—	—	18 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Nets: Missing, negative parasite density	—	—	—	—	130 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main house construction material of Nets: Missing, missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main source of the drinking water: Closed water source, low parasite density	388 Participants	357 Participants	377 Participants	334 Participants	366 Participants	438 Participants	461 Participants	340 Participants	322 Participants	280 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main source of the drinking water: Closed water source, medium parasite density	172 Participants	145 Participants	116 Participants	139 Participants	144 Participants	160 Participants	127 Participants	112 Participants	129 Participants	128 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main source of the drinking water: Closed water source, high parasite density	67 Participants	66 Participants	52 Participants	53 Participants	63 Participants	68 Participants	81 Participants	57 Participants	48 Participants	45 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main source of the drinking water: Closed water source, very high parasite density	94 Participants	91 Participants	72 Participants	91 Participants	103 Participants	126 Participants	112 Participants	85 Participants	103 Participants	78 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main source of the drinking water: Open water source, medium parasite density	114 Participants	135 Participants	85 Participants	70 Participants	89 Participants	125 Participants	88 Participants	60 Participants	62 Participants	65 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main source of the drinking water: Open water source, high parasite density	59 Participants	45 Participants	19 Participants	29 Participants	47 Participants	47 Participants	33 Participants	32 Participants	27 Participants	27 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main source of the drinking water: Open water source, very high parasite density	61 Participants	77 Participants	38 Participants	55 Participants	75 Participants	71 Participants	67 Participants	73 Participants	61 Participants	45 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main source of the drinking water: Open water source, negative parasite density	951 Participants	1019 Participants	413 Participants	551 Participants	900 Participants	1195 Participants	1373 Participants	1350 Participants	1331 Participants	1419 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) Main source of the drinking water: Open water source, missing	—	—	—	—	0 Participants	—	—	—	—	—
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) The open source is in compound: Yes, low parasite density	64 Participants	98 Participants	57 Participants	17 Participants	27 Participants	34 Participants	29 Participants	9 Participants	26 Participants	32 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) The open source is in compound: Yes, medium parasite density	21 Participants	34 Participants	10 Participants	8 Participants	7 Participants	25 Participants	11 Participants	5 Participants	13 Participants	12 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) The open source is in compound: Yes, high parasite density	12 Participants	10 Participants	2 Participants	4 Participants	7 Participants	7 Participants	0 Participants	1 Participants	3 Participants	3 Participants
Number of Participants Experiencing Malaria Risk Factors Categorized by House Information (by Parasite Density) The open source is in compound: Yes, very high parasite density	17 Participants	14 Participants	7 Participants	9 Participants	9 Participants	16 Participants	14 Participants	5 Participants	9 Participants	8 Participants

Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

GSK Response Center

GlaxoSmithKline

Phone: 866-435-7343

Email: [email protected]

Results disclosure agreements

Principal investigator is a sponsor employee GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single site data not precede the primary publication of the entire clinical trial.
Publication restrictions are in place

Restriction type: OTHER